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AMP-DNM N-(5-adamantane-1-yl-methoxy)pentyldeoxynojirimycin 
BME  Basal Modified Eagle’s Mediumù 
CBE  Conduritol B Epoxide 
Cer  Ceramide 
DMEM  Dulbecco Modified Eagle’s Medium 
EIPA  5-(N-Ethyl-N-isopropyl)amiloride 
FBS   Fetal bovine serum 
GBA2  Non-lysosomal -glucosylceramidase 
GlcCer  Glucosyl ceramide 
GSL  Glycosphingolipid 
Hex  Hexosaminidase 
HMU-PC 6-Hexadecanoylamino-4-methylumbelliferyl-phosphorylcholine  
HPTLC  High performance thin layer chromatography 
LacCer  Lactosyl ceramide 
LacCer  Lactosylceramide 
MEM  Minimum Essential Medium with Earle’s Salt 
MUB  4-Methylumbelliferone 
MUB-Gal 4-Methylumbelliferyl--D-galactopyranoside 
MUB-Glc 4-Methylumbelliferyl--D-glucopyranoside  
MUG  4-Methylumbelliferyl--N-acetylglucosaminide 
MUGS  4- Methylumbelliferyl--N-acetylglucosaminide-6-sulphate 
Neu3  PM associated sialidase 
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PAGE  Polyacrylamide gel electrophoresis 
PBS  Phosphate buffered saline 
PM  Plasma membrane 
PVDF  Polyvinylidene di fluoride 
SM  Sphingomyelin 
SMase  Sphingomyelinase 
ST-1  GM3 synthase, CMP-NeuAc: LacCer α2-3 sialyltransferase 
ST-II  GD3 synthase, CMP-NeuAc: GM3 α2-8 sialyltransferase 
ST-IV  CMPNeuAc: GA1/GM1/GD1b/GT1c α2-3 sialyltransferase 
-Gal  -Galactosidase 
-GlC  -Glucosidase 
 
Ganglioside nomenclature is in accordance with IUPAC-IUBMB recommendations (IUPAC-IUBMB 
1998) 
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Plasma membrane (PM) sphingolipid pattern and content are the result of a complex 
network of metabolic pathways, including those potentially involving the activity of PM 
sphingolipid hydrolases  and sphingolipid synthases (1, 2). In human fibroblasts it has been 
observed a crosstalk between the expression and the activity of membrane associated 
glycohydrolases (3), furthermore, qualitative and quantitative changes in glycosphingolipids, 
together with changes in the expression of the corresponding glycosyltransferases, have 
been reported along neuronal differentiation and aging (2, 4-8).  
Using human fibroblasts we set up an HTA (high throughput assay) method able to measure 
the activity of -galactosidase, CBE sensitive -glucosidase, GBA2 -glucosidase, SMase and 
-hexosaminidases, enzymes working directly at the plasma membrane level using MUB 
derivates as substrate. Afterwards we applied this assays in order to study these PM 
associated activities in rat cerebellar granule cells along differentiation and aging in culture.  
We started to characterize the kinetic parameters of these enzymes working directly on the 
external leaflet of the PM in living cells: first of all, we performed an assay using cell cultured 
medium at different pH. Our data showed higher activity of CBE sensitive -glucosidase at 
pH 6.2, GBA2 -glucosidase at pH 5.7, -hexosaminidase at pH 5.10 while -galactosidase, 
SMase and -hexosaminidase A at pH 5.45. We could distinguish between CBE sensitive -
glucosidase and GBA2 -glucosidase using specific inhibitors that are CBE and AMP-DNM 
respectively, therefore we determined Km and Vmax of CBE sensitive -glucosidase and 
GBA2. Thought the pH conditions are not those typically associated with the PM, at least 7 
different families of transporters/exchangers are present at this level and are capable of 
varying the pH locally. In order to verify whether the varying of the membrane potential 
acting on these pumps can influence also the activity of these enzymes, we carried out 
preliminary experiments using EIPA, an inhibitor of NHEs (Na+/H+) exchangers. What we 
achieve is that exists a correlation between the action of the pump and the enzymes. So, all 
our data confirm the presence of this PM associated activities. This could play an important 
role in the cell social life and in particular our data show an involvement of sphingolipid 
hydrolases during the neuronal differentiation. 
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PLASMA MEMBRANES 
The surface of eukaryotic cells is a complex assembly of a variety of molecular components 
which actively partitions the interior of the cell from the external environment. Plasma 
membrane is composed of a double layer of lipids where many diverse proteins are 
embedded while others are simply associated by lipid anchors. The lipid composition of the 
plasma membrane (Figure 1) is extremely complex, consisting of an incredible list of 
different lipid species, classified according to head-group and backbone structures. These 
include glycerophospholipids, sphingolipids and cholesterol (9, 10). 
  
10
  
 
The eukaryotic cell is functionally compartmentalized via membrane-limited organelles that 
continually exchange biomolecules by a variety of membrane trafficking mechanisms (11, 
12). In the face of this dynamic exchange, heterogeneity in the lipid composition of the 
membranes of different organelles appears to be maintained. For instance, the plasma 
membrane is highly enriched in cholesterol and glycosphingolipids, while the endoplasmic 
reticulum (ER) is poor in these components (13, 14). In addition, there is a transbilayer lipid 
compositional asymmetry within the same membrane (9) that could have important 
functional consequences. A dramatic demonstration is represented by what occurs during 
apoptosis when the predominantly inner-leaflet lipid species, phosphatidylserine, fails to be 
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actively ‘flipped’ and accumulates at the outer leaflet, thus serving as a signal for clearance 
of apoptotic cells by macrophages with scavenger functions (15, 16). Although precise details 
of how compositional heterogeneity is achieved are not available, it is abundantly clear that 
this is done by a complex mechanism involving lipid synthesis, turnover and active transport.  
A great contribute to determine the high complexity of the plasma membrane organization 
and of its function is also given by the protein components. Plasma membrane proteins 
function in several different ways: many of them play a role in the selective transport of 
certain substances across the phospholipid bilayer, either acting as channels or active 
transport molecules. Others function as receptors, which bind information-providing 
molecules, such as hormones, and transmit corresponding signals based on the obtained 
information to the interior of the cell. Membrane proteins may also exhibit enzymatic 
activity, catalyzing various reactions related to the plasma membrane. 
 
MEMBRANE LIPIDS 
The two highly heterogeneous groups of glycerophospholipids and of sphingolipids are, 
together with cholesterol, the complex lipid components of cell membranes.  
 
GLYCEROPHOSPHOLIPIDS 
Glycerophospholipids are glycerol-based phospholipids and they are the main lipids of 
eukaryotic cell membranes. They consists of a small polar head group (at the inner and outer 
surfaces of the cell membrane) and two long hydrophobic chains (pointing to each other and 
forming a fatty, hydrophobic centre). 
 
SPHINGOLIPIDS 
Sphingolipids are minor cell components, residing in the external layer of the plasma 
membrane (17) with the hydrophilic head group protruding toward the extracellular 
environment. Many reports indicated multiple functional roles for membrane sphingolipids, 
including the modulation of the properties of important membrane enzymes (18-22). The 
lipid moiety of sphingolipids is named ceramide (Figure 2). Ceramide is the most simple 
sphingolipid and it is constituted by a long chain amino alcohol, 2-amino-1,3-dihydroxy-
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octadec-4-ene, whose trivial name is sphingosine (Figure 3) connected to a fatty acid by an 
amide linkage. Of the four possible configurations of sphingosine, only the 2S,3R is present in 
nature (23, 24).  
  
 
Ceramide is the common precursor of complex sphingolipids, which are synthesized by 
addition of polar molecules to hydroxyl group in position 1 of the sphingoid base (25). The 
different classes of sphingolipids are characterized by different polar groups: 
phosphocholine is found in sphingomyelin (SM), monosaccharides in cerebrosides, 
saccharidic chains in complex glycolipids. Gangliosides are a peculiar class of acid glycolipids, 
that get their acidity from sialic acid (26). 
The glycolipids are clearly significant contributors to the structure of the outer leaflet of 
most eukaryotic cell membranes. The molar ratio of these molecules relative to the other 
major membrane lipids (phospholipids, cholesterol, and glycerolipids) varies from being 
rather minor (e.g. <5% in erythrocytes) to being a very major component (e.g., 30% of the 
total lipids in neuronal plasma membranes). Although glycolipids are found throughout all 
eukaryotes, the nature of the core structures can vary in different taxa. Ceramide, and 
inositolphosphate-amides are major sphingolipids in fungi and plants. Variations in type, 
number, linkage and further modification of sugar and sialic acid residues within the 
oligosaccharide chain but also the different composition of the lipid moiety give rise to a 
combinatorial variety (27) of naturally occurring glycosphingolipids (GSLs).  
They can be classified into series, which are characteristic for a group of evolutionarily 
related organisms. Apart from the species dependence, GSLs form cell-type specific patterns 
on the cell surface. In particular sialic acid containing GSLs of the ganglio-series, the 
gangliosides, are abundant on neuronal cells and contribute to the function of the nervous 
system. Cell surface glycolipid patterns change with cell growth, differentiation, viral 
transformation and oncogenesis (28). Cell-type-specific glycolipid expression and stable lipid 
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patterns indicate a tight regulation of their biosynthesis, degradation and intracellular 
transport (29). 
In humans, inherited defects of GSL- and sphingolipid catabolism give rise to lysosomal 
storage diseases, the sphingolipidoses: the function of animal glycosphingolipids has been 
analysed in cells from human patients with defects in sphingolipid catabolism (27).  
 
CHOLESTEROL 
Cholesterol, which is the third main important constituent of cell membranes, has a rigid ring 
system and a short branched hydrocarbon tail. Cholesterol is largely hydrophobic but it has 
one polar group, a hydroxyl, making it amphipathic. Cholesterol is an important lipid in this 
context since it is known to regulate the function of neuronal receptors and thereby 
affecting neurotransmission. Although the brain is highly enriched in cholesterol, the 
organization and dynamics of brain cholesterol is still poorly understood. Brain cholesterol is 
synthesized in situ and is developmentally regulated. The organization, traffic, and dynamics 
of brain cholesterol are stringently controlled since the input of cholesterol into the central 
nervous system is almost exclusively from in situ synthesis as there is no evidence for the 
transfer of cholesterol from blood plasma to brain (30). 
 
ROLE OF GLYCOSPHINGOLIPIDS 
The vast range of head group structures found on the cell surface suggest that they play an 
important role in cell signalling and cell activation. In addition, the expression pattern of 
GSLs undergoes certain changes during development and neoplastic transformation, since 
GSLs acts as a receptor sites in cell-cell recognition (figure 4). They form cell type specific 
profiles which characteristically change in development, differentiation and oncogenic 
transformation, suggesting their implication in fundamental cellular processes like: 
 growth 
 differentiation 
 morphogenesis 
 cell to matrix interaction  
 cell to cell communication 
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There are many putative biological roles of glycosphingolipids, of which only a few have 
been conclusively established (Figure 4).  
 
 
     
 
From a physical point of view, glycosphingolipids may have an organizing role in the cell 
membrane. For example, glucosylceramides (GlcCer) and ceramides are thought to be 
critical components of the epidermal permeability barrier. In this regard, it is noteworthy 
that they are similar to glycophospholipid (GPI) anchors having long acyl chains (24–26 
carbons). It is thought that this common structural feature allows both types of lipids to 
Ceramide moiety
•insertion of GSL in defined orientation in 
cellular membranes
•generation of bioactive sphingoid
molecules
Cell adhesion mediators
Lectins (selectins, siglecs)
carbohydrates
Tumor-associated, 
developmentally-
regulated antigens
Allogeneic antigenes
Receptors
Microbial exotoxins
Microbial adhesion
Oligosaccharide chain
• interactions with extracellular molecules 
(“social life” of the cell)
Initiators of signal transduction
through GSL signaling domain
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extend into the inner leaflet of the phospholipid bilayer of cell membranes and also causes 
them to associate with each other and with cholesterol, forming putative “rafts” in the 
micromembrane (some investigators report the existence of distinct glycosphingolipid-
enriched domains free of cholesterol that are thought to be involved in signal transduction 
via cytosolic proteins) (31). Such aggregations of glycosphingolipids and GPI-anchored 
proteins are thought to form in the trans-Golgi region and then get targeted to the apical 
domains of polarized epithelial cells that line the lumen of various body cavities. Here, they 
can represent as much as 50% of the total lipid concentration of the outer leaflet of the 
apical membrane, likely providing physical protection against the hostile environment often 
encountered in such lumens, as well as specific binding sites for the adhesion of symbiotic 
bacteria. In the same location, other structural aspects of the same molecule can be utilized 
as highly specific receptor targets for a variety of bacteria, toxins, and viruses. The classic 
and well-established finding is that the  subunit of cholera toxin binds to the ganglioside 
GM1, triggering a conformational change and delivering the toxic subunit to the interior of 
the cell. 
A recurring theme in the literature is the specific physical association of certain 
glycosphingolipids with certain cell membrane receptors. Although the physical mechanism 
of such interactions is not certain, there is considerable evidence indicating that they can 
alter the biology of these receptors. For example, the tyrosine phosphorylation of the 
epidermal growth factor (EGF) receptor is specifically down-regulated by adding the 
ganglioside GM3, whereas the closely related structure sialylparagloboside has a similar 
effect only on the insulin receptor. A small modification of the GM3 molecule (de-N-
acetylation) results in exactly the opposite response (stimulation of EGF receptor tyrosine 
phosphorylation). Related studies demonstrate the opposing effects of GM3 and LacCer on 
cell growth. However, many of these effects are demonstrated following the exogenous 
addition of glycosphingolipids to cells. Thus, although at least a portion of the added 
glycosphingolipids are incorporated into the membrane, one cannot rule out other effects 
caused by the micellar forms of the added glycosphingolipids that can also be bound to cell 
surface proteins. In balance, the stereospecificity of these effects for the fine structure of 
the glycan portion of the glycosphingolipids implies that defined mechanisms must be 
involved. 
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Similar findings have been reported for the specific effects of ganglioside GQ1b in inducing 
neuritogenesis, and a suggestion has been made that this involves the NGF receptor and/or 
an ectoprotein kinase. Again, final mechanistic conclusions are lacking. Regardless, these 
findings have encouraged other investigators to try ganglioside infusions in a variety of 
central nervous system disorders, including stroke and demyelinating disorders. Particularly 
in stroke, there are several reports of beneficial effects of infusing gangliosides into the 
bloodstream of patients. Likewise, direct topical applications of conduritol B epoxide, a 
specific irreversible inhibitor of β-glucocerebrosidase, increased GlcCer levels in the basal, 
proliferative cell layer (four fold increase) and stimulated proliferation. Simultaneous 
treatment with conduritol B epoxide plus GlcCer resulted in an additive increase in DNA 
synthesis, strongly suggesting that GlcCer directly stimulates epidermal mitogenesis. 
It has also been suggested that gangliosides are involved in thermal adaptation of neuronal 
membranes. The data suggest a general rule that “the lower the environmental temperature 
the more polar is the composition of brain gangliosides.” Studies with model bilayer 
membranes also indicate that gangliosides can modulate basic membrane properties in a 
thermosensitive manner. 
In polarized cells such as epithelia, most GSLs are enriched in the apical, rather than the 
basolateral, surface (32, 33). GSLs are known to be of vital structural and functional 
importance to cells and to be extensively involved in various aspects of cell regulation. They 
participate in cell differentiation and intercellular communication events, for example, by 
controlling cell adhesion, mediate diverse functions of the immune system, and modulate 
membrane-bound enzymes and receptors (34). Specific gangliosides were identified as 
binding sites for toxins (35), viruses (36) and bacteria (37), and as co-receptors for hormones 
and growth factors (36). Several lines of evidence indicate that gangliosides contribute vitally 
to the function of the nervous system, for example, as modulators of neuronal calcium or 
neuronal differentiation and development (38). Several lipophilic products of GSL 
metabolism such as sphingosine and ceramide were found to function as signal transducing 
molecoles (39). Furthermore, others results suggest that GSLs are involved in the formation 
of rafts and caveolae and may thereby contribute to various signal transduction processes 
(40). In fact GSLs are not randomly distributed on the plasma membrane, but rather 
concentrated in restricted membrane areas (41, 42) due to their spontaneous segregation 
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respect to glycerophospholipid: it can be predicted that their local concentration in specific 
“lipid membrane domains” is very high. 
 
SPHINGOLIPIDS AND NEURONS 
Remarkably, membrane segregation of SL seems to be higher in neurons (43-46) than in any 
other cell type so far investigated. The presence of (glyco)sphingolipids deeply affects the 
structural properties of the cellular membrane. GSLs included in PC bilayers imply a 
curvature stress to the membrane that is probably relevant in the stabilization of the 
architecture of polarized cell membrane areas (such as the pre- and postsynaptic areas in 
neurons) and for the membrane geometry dynamics in processes such as vesiculation and 
budding. For this reasons the understanding of the metabolic regulation and the roles of 
sphingolipids is a major challenge, and particular attention has been paid to determining the 
roles of sphingolipids in neuronal development and in the central nervous system (CNS). 
It is possible to observe drastic and consistent changes in ganglioside expression during 
neuronal development, particularly during the earliest stages. Many studies have shown that 
the qualitative and quantitative changes in ganglioside expression in the nervous system 
correlate with certain cellular events during development.  
These observations, followed by several report, indicate the vital importance of 
glycosphingolipids in the “cell social life” and in particular regarding the relationship 
between GSL expression and cellular events in the development of the vertebrate nervous 
system, including that of humans (4-8). Available evidence indicates that GSLs have specific 
functional roles essential for survival, proliferation and differentiation during brain 
development including control of neuritogenesis (22, 47, 48), modulation of receptor and 
proteins and synaptic transmission (49) and cell-to-matrix interactions (50). 
The crucial role of GSL in the development and maintenance of the proper functions of 
nervous system has been demonstrated by different evidences: 
 GSL patterns undergo deep qualitative and quantitative modifications during the 
development of the nervous system: in chicken (51), rodent (52), and human brain (4), 
the total gangliosides content increases a lot in the postnatal life compared to the 
embryonic stages. These increases were accompanied by a dramatic shift from simple 
gangliosides (GM3 and GD3) to more complex species (GM1, GD1a, GD1b, GT1b). A 
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similar increase in the amount and in the complexity of gangliosides has also been 
observed during differentiation in cultured neurons of different origin and in mouse 
neural precursor cells (51-60). In humans, the phase of rapid ganglioside increase 
started from the sixth month of gestation reaching the maximum value at about 5 
years of age. Along the adult life, a progressive loss of gangliosides with aging has been 
reported in human and mouse brain. During mild-embryonic stages of mouse brain 
development, GlcCer, but not GalCer or sulfatide, is expressed (52). Their synthesis 
starts in the embryonic development when oligodendrocytes enter terminal 
differentiation and is upregulated during the postnatal extension of the myelin sheaths 
(61). 
 Experimental manipulations allowing modification of the concentration or pattern of 
GSL in the plasma membrane profoundly affect the behavior of neural cells. The 
addition of exogenous gangliosides exerts neuritogenic, neurotrophic, and 
neuroprotective effects in cultured neurons and neural cell lines and in animal models 
of neural lesions (22, 62-65). In particular, GM1 ganglioside is able to potentiate the 
neuritogenic effect of nerve growth factor (NGF) in PC12 cells, i.e., it is able to induce 
neuronal differentiation in the presence of an NGF concentration that is ineffective by 
itself (66-68). Increased surface expression of GM1, by treatment cells with bacterial 
sialidase, potentiated PGE1-induced neurite formation (69, 70). Furthermore, 
administration of exogenous GM1 and GM3 induced c-Src activation and 
neuritogenesis in neuroblastoma cells (71). Treatment with pharmacological inhibitors 
of ceramide synthase or ceramide glucosyltranferase, or selective depletion of cell 
surface SL, achieved by treating living cells with bacterial sphingomyelinases (72, 73)or 
with endoglycoceramidase (able to remove the oligosaccharide chain from cell surface 
GSL) (74), caused SL depletion and disorganization of SL-enriched domains (75-79), 
thus affecting domain-mediated biological functions, including survival in 
neurotumoral cell lines and oligodendrocytes, axonal transport and sorting (80-83), 
and finally TAG-1 signaling in cerebellar neurons (74).  
 Many pieces of evidence indicated that SL biosynthesis is necessary for nervous system 
development. Blockade of (glyco)sphingolipid biosynthesis by pharmacological 
inhibition of GlcCer synthase or ceramide synthase reduced axonal elongation, 
branching synapses formation and activity (84) in cultured hippocampal and 
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neocortical neurons (85, 86), behind to this a pharmacologically inhibition of the -
glucocerebrosidase with CBE caused an increase in the number of axonal branches and 
a corresponding increase in the length of the axon plexus. Neural cell-specific deletion 
of GlcCer synthase in mice led to severe neurological defects in the early postnatal life 
and death within 3 weeks (87), demonstrating the importance of GSL for the 
maturation of the nervous system. On the other hand, pharmacologically induced 
stimulation of GSL biosynthesis stimulated neurite outgrowth, formation of functional 
synapses and synaptic activity in cultured cortical neurons (84, 88), and the induced 
expression of GD3 synthase was able to switch neuroblastoma cells to a differentiated 
phenotype (89). NGF- and forskolin-induced neuronal differentiation in PC12 cells was 
accompanied by the up-regulation of several glycosyltransferase activities (GalGb3-, 
GM3-, GD1a- and GM2 synthases) (90), and bFGF-stimulated axonal growth in cultured 
hippocampal neurons resulted in the activation of ceramide glucosyltranferase (91). It 
has been recently suggested that the activity of the plasma membrane-associated 
ganglioside sialidase Neu3 might have a role in modifying the cell surface ganglioside 
composition, causing a decrease of GM3 and shift from polysialylated ganglioside 
species to GM1, with deep consequences on very important cellular events, including 
neuronal differentiation. In neuroblastoma cell lines, Neu3 expression increased during 
pharmacologically induced neuronal differentiation, and Neu3 gene transfection 
induced neurite outgrowth (92) and enhanced the effect of differentiating agents on 
the extension or branching of neurites (93). Conversely, inhibition of plasma 
membrane sialidase activity resulted in the loss of neuronal differentiation markers 
(94-96). In cultured hippocampal neurons, Neu3 activity regulated the local GM1 
concentration, determining the neurite’s axonal fate by a local increase in TrkA activity 
(97) and affecting axonal regeneration after axotomy (98). 
It was recently reported that the sialidase Neu4 was dominantly expressed in the mouse 
brain (99-101) and its expression was relatively low in the embryonic stage and then rapidly 
increased at 3-14 days after birth. Moreover during retinoic acid-induced differentiation, 
Neu4 expression was down-regulated in Neuro2a cells and the overexpression of Neu4 
resulted in suppression of neurite formation; on the contrary Neu4 inhibition increases 
neurite formation (92, 93, 97, 98). Total beta galactosidase activity was increased during the 
aging of the rat hippocampus in vitro and in vitro experiments (102). These results suggest 
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that a shift of ganglioside expression during development is regulated by changes of the 
expression level and activity of these key glycosyltransferases. Not only gangliosides but also 
other GSLs, such as GalCer and sulfatide, present drastic pattern shifts during development.  
The multiple roles of GSL in regulating cellular functions, essential for the development and 
the homeostasis of the nervous system, can be explained by their ability to modulate the 
activity of plasma membrane via direct SL–protein or indirect (mediated by lipid rafts) lateral 
interactions (cis interactions), as discussed above (2, 31, 83, 103-105).  
 
BIOSYNTHESIS 
Glycolipid biosynthesis in animals requires the intracellular formation of the membrane 
anchor (106) and the subsequent addition of single carbohydrate residues (27). Both events 
are coupled to intracellular movement of metabolic intermediates and final products to the 
plasma membrane (29). The combinatorial variety of naturally occurring glycosphingolipids 
can be largely attributed the combination of glycosyltransferase activities found in different 
species and cell types. 
 
CERAMIDE 
The de novo biosynthetic pathway of sphingolipids starts at the cytosolic face of the 
endoplasmic reticulum (ER), where enzyme activities responsible for the reaction sequence 
leading to the formation of ceramide are localized. Ceramide synthesis (Figure 5) is due to 
the condensation of the amino acid L-serine with a fatty acyl coenzyme A, usually palmitoyl 
coenzyme A, to 3-ketosphinganine and it is catalysed by the enzyme serine palmitoyl-
transferase (SPT) (107-109). In the following NADPH-dependent reaction, 3-ketosphinganine 
is reduced to D-erythro-sphinganine by 3-ketosphinganine reductase (110). Sphinganine is 
subsequently acylated to dihydroceramide by a N-acyltransferase (111-113). The major part 
of the dihydroceramide pool is desaturated to Cer in the dihydroceramide desaturase 
reaction (114-116).  
Ceramide synthase is able to use as substrate both sphingosine and sphinganine with similar 
efficiency (117), so ceramide can be also formed by N-acylation of sphingosine produced by 
the catabolism of complex sphingolipids. 
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Ceramide is also generated during the catabolism of complex sphingolipids (Figure 6). The 
catabolism occurs in the lysosomes by the action of  glycohydrolases that remove single 
saccharidic units from the not reducing extremity of the oligosaccharides head group of GSL. 
Ceramide can be also produced by the SM hydrolysis is catalyzed by the action of 
sphingomyelinases (SMases) (118, 119). Different forms of SMases are known, which are 
characterized by specific optimum pH, subcellular localization, cation dependence.  
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SPHINGOMYELIN AND SPHINGOLIPIDS  
The neo-synthesized ceramide could reach directly the membrane or it is used as common 
precursor for glycosphingolipid or sphingomyelin biosynthesis. In both cases the ceramide 
reaches the Golgi apparatus by a not well defined mechanism (29), capable to address the 
synthesis of SM or GSL. Synthesis of SM occurs via addition of phosphocholine group to the 
hydroxyl group in position 1 of the sphingoid base of the ceramide. In the case of the 
biosynthesis of glycosphingolipids, different membrane-bound glycosyltransferases are 
responsible for the sequential addition of sugar residues to the hydroxyl group in position 1 
of the ceramide, leading to the growth of the oligosaccharide chain.  
Glucosylceramide (GlcCer) is the first glycosylated product, formed by a ceramide 
glucosyltransferase activity localized at the cytosolic side of the early Golgi membrane (120). 
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Glucosylceramide can either directly reach the plasma membrane (121), presumably 
transported in a non-vesicular way (121), or be translocated to the luminal side of the Golgi, 
where it is further glycosylated by other glycosyltransferases located in this cellular district 
to generate more complex glycosphingolipids. Lactosylceramide(LacCer), the common 
precursor for the GSL series found in vertebrates, is formed by the addition of a galactose 
moiety from UDP-Gal to GlcCer catalysed by galactosyltransferase. The enzyme has been 
purified and cloned from rat brain (122). LacCer formation and also the reactions leading to 
higher glycosylated lipids occur on the luminal leaflet of Golgi membranes (123). Neo-
synthesized glycosphingolipids move through the Golgi apparatus to the plasma membrane 
following the mainstream exocytotic vesicular traffic (Figure 9).  
Hundreds of sphingolipid molecular species, differing in their polar head group, sphingoid 
base, and fatty acyl moiety, have been described. Referring to the polar head group it is 
possible to distinguish a very wide group, inside the large family of the sphingolipid, 
represented by glycosphingolipids (GSLs) that are amphipathic molecules composed of a 
hydrophilic carbohydrate chain and a hydrophobic ceramide moiety (124). GSLs containing 
one or more sialic acid residues in the carbohydrate chain are referred to as gangliosides. 
Based on the sequences of the core carbohydrate residues, GSLs are classified into a number 
of series (including gala-, ganglio-, isoganglio-, lacto-, neolacto-, lactoganglio-, globo-, 
isoglobo-, and muco-series) (Figure 7). Structural diversity in their carbohydrate chains is a 
hallmark of GSLs. At present, 172 neutral GSLs, 24 sulfated GSLs, and 188 gangliosides with 
variations in the carbohydrate chain have been reported in a variety of vertebrate tissues 
and organs (125). This complexity is increased many fold when heterogeneity in the 
lipophilic components is taken into consideration. 
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COMPLEX GANGLIOSIDES 
A GSL series that is especially abundant on neuronal cells is the ganglio series. The 
biosynthesis of sialic acid-containing GSLs of this series, the gangliosides, is catalysed by 
glycosyltransferases in the lumen of the Golgi apparatus (27, 126, 127). Gangliosides are 
structurally and biosynthetically derived from LacCer. LacCer and the hematosides GM3, 
GD3 and GT3, serve as precursors for complex gangliosides of the o-, a-, b- and c-series 
(Figure 8). In adult human tissues, gangliosides from the o- and c-series are found only in 
trace amounts. The transferases that catalyse the first steps in ganglioside biosynthesis show 
high specificity towards their glycolipid substrates, i.e. for the formation of LacCer, GM3 and 
GD3. The relative amounts of these glycosphingolipids in the steady state seems to 
determine the amount of o-series glycosphingolipids, which are derived only from LacCer, a-
series gangliosides which are only derived from ganglioside GM3, and b-series gangliosides 
which are only derived from ganglioside GD3. Sialyltransferases I and II are much more 
specific for their glycolipid substrates than sialyltransferases IV and V, or than 
galactosyltransferase-II and GalNAc transferase. It was assumed that different transferases 
catalyse the formation of homologous gangliosides of different series.  
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Recent results suggest that in some cell types recycling of partially degraded GSLs in the 
recovery pathway is of considerable importance for the synthesis of GSLs (123). The 
regulation of GSL biosynthesis, as well as the factors that account for stable GSL patterns on 
individual cell surfaces and the characteristic changes observed during development and 
malignant transformation, is currently under active investigation (128, 129). A dominant 
regulatory role can be ascribed to glycosyltransferase activities, which appear to be 
controlled mainly at the transcriptional level. In addition, epigenetic regulation mechanisms 
are considered. In vitro, feed back control of several glycosyltransferases either by their 
reaction product or the final product within the series has been observed.  
Furthermore, the enzymes activities were found to be dependent on their phosphorylation 
status and the pH value. On the other hand, the extent of cell surface sialylation depends on 
the activity of UDP-GlcNAc 2-epimerase, the key enzyme in sialic acid biosynthesis. In 
contrast to the great number of inherited human diseases attributed to disorders in GSL 
catabolism, nothing is described about defects in GSL biosynthesis. It may be assumed that 
incorrect GSL patterns on the cell surface resulting from disorders in GSL biosynthesis would 
severely impair morphogenesis and prevent embryonic development. Recently, the targeted 
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disruption of the glucosylceramide-synthase gene in mice led to impaired embryogenesis 
and demonstrated conclusively the critical necessity of GSLs for embryonic development and 
tissue differentiation (130, 131). 
 
CATABOLISM 
Another important point of regulation of plasma membrane sphingolipids composition is the 
lipidic degradation that occurs in the acidic compartments of the cells, the lysosomes, where 
sphingolipids are transported by the endocytic vesicular flow through the early and late 
endosomal compartment to be catabolyzed (Figure 9).  
Lysosomal glycosidases sequentially cleave off the sugar residues from the non-reducing end 
of their glycolipid substrates. All the enzymatic steps of the degradative process require an 
acidic pH inside the organelle, a condition that is warranted by the action of a proton pump 
that brings H+ into the lysosomes (132).The resulting monosaccharides, sialic acids, fatty 
acids and sphingoid bases can leave the lysosome and be used within recovery processes or 
can be further degraded.  
Portions of the plasma membrane enriched in GSLs bud into coated pits that are 
internalized, uncoated and subsequently fuse with early endosomes. 
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Degradation of sphingolipids derived from the cell surface that become part of the limiting 
membrane of endosomes and lysosomes is prevented by the thick glycocalyx, which protects 
the membrane from the attack of the lipid-degrading enzymes present in the lysosome 
(133). This glycocalyx is composed of the carbohydrate part of lysosomal integral membrane 
proteins and lysosomal associated membrane proteins (134) which are highly N-glycosylated 
with lactosamine units. The enzyme/activator system required for degradation cannot reach 
their substrates through this glycocalyx. This explains why glycosphingolipids of the 
perimeter membrane are much more resistant towards degradation than plasma 
membrane-derived GSL (135). 
Experimental evidences have recently shown that the major part of GSL catabolism occurs 
on small intra-endosomal and intra-lysosomal compartment (136). Additional evidence for 
the proposed route came from experiments in human fibroblasts: biotin-labelled ganglioside  
GM1 derived from the plasma membrane is mainly targeted to intra-lysosomal structures 
and much less to the lysosomal perimeter membrane (137, 138). If degradation occurs on 
the surface of these intra-lysosomal membrane structures, lipid composition and lateral 
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pressure should influence the degradation process. Analysis of these molecular details 
supports the initial hypothesis of GSL degradation at intra-lysosomal membrane structures. 
According to the model discussed above, the degrading lysosomal enzymes cleave substrates 
that are part of intralysosomal membrane structures. In the absence of detergents that 
solubilize the lipids, GSL with carbohydrate chains of one to four residues (139) are not 
sufficiently accessible to the hydrolytic water-soluble enzymes in the absence of a 
membrane perturbing activator protein. For this reason the intralysosomal degradation of 
most, if not all, glycosphingolipids requires, besides exoglycohydrolases, effector protein 
molecules named “sphingolipid activator proteins (SAPs, or saposines)” (132). 
The sequence of sugar removal from gangliosides within the lysosomes is as follows: firstly, 
multi-sialogangliosides are transformed by the lysosomal sialidase into the corresponding 
mono-sialogangliosides GM1 and GM2 (which are resistant to this enzyme) (Figure 10). The 
linkage of sialic acid in sialic acid containing molecules is hydrolyzed by several different 
sialidases. Neu1 is the lysosomal enzyme, known from long time to be the enzyme for the 
catabolism of sialo-compounds. Neu2 is prevalently located in the cytosol whereas the two 
isoforms of Neu4, the short and the long, are  associated to internal membranes and 
mitochondria, respectively. However the role of Neu2 and Neu4 is still not clear in vivo. Neu3 
is the plasma membrane sialidase. Only from 2000 Neu3 structure was elucidated, resulting 
distinct from that of the other known sialidases, being cloned in human (140), bovine (141) 
and mouse (93).  
 
 
 
From GM1, galactose is then removed by a β-galactosidase, working in the presence of 
either the GM2-AP or SAP-B (139), to produce GM2 (Figure 11). β-galactosidase are 
glycohydrolytic enzymes that removes β-galactosides from various sialo derivatives 
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catalyzing the hydrolyses of -galactosides into monosaccharides. Substrates of different β-
galactosidases include ganglioside GM1, LacCer, lactose, and various glycoproteins. 
 
 
 
The resulting ganglioside GM2 is cleaved to ganglioside GM3 and N-acetyl-galactosamine 
only by the β-hexosaminidase isoenzymes Hex A which requires the GM2-AP, an activator 
that is essential for the in vivo degradation of the GM2 gangliosides (Figure 12). 
 
 
 
The heterodimer Hex A (αβ) has two active sites that differ in their substrate specificity (142-
144) and its presence in the external leaflet of PM has been demonstrated in cultured 
fibroblasts (145). The other subunit combinations in the hexosaminidase enzymes are Hex B 
(ββ-homodimer) and Hex S (αα-homodimer). The catalytic centre of the β-subunit cleaves 
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predominantly neutral sugars chains with terminal N-acetyl-β-D-galactosaminyl and N-
acetyl-β-D-glucosaminyl residues. Towards uncharged substrates, the active site on the α-
subunit is less active than the β-unit, but cleaves sugars from negatively charged substrates 
(146). The enzyme binds another molecule called GM2 activator protein (Figure 13) in order 
to form this complex that can hydrolyzes GM2 ganglioside removing -1,4-linked N-
acetylhexosamine residue. 
 
 
 
In some cells and animals, sialic acid is removed from GM1 and GM2 by a specific sialidase 
(GM1- and GM2- sialidase) producing the corresponding a-sialo derivatives GA1 and GA2, 
that, by the action of β-galactosidase and β-hexosaminidase or only β-hexosaminidase 
respectively, are converted to LacCer. The presence of GM2- and GM1-sialidase, first 
described in 1971 (147), was definitely confirmed later (148-150). LacCer is produced also 
directly from GM3 by the action of a sialidase which cleaves this ganglioside into LacCer and 
sialic acid in a reaction stimulated by SAP-B (151). LacCer is then degraded to ceramide by 
the sequential action of a β-galactosidase (in the presence of either SAP-B or –C) and β-
glucosidase (152) (which is a glucosidase enzyme which acts upon -1,4 bonds linking two 
glucose) (Figure 14). 
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Ceramide is cleaved by acid ceramidase in the presence of SAP-D (153) into sphingosine and 
a fatty acid. Together with the other cleavage products, these two metabolites are able to 
leave the lysosome. An alternative pathway for ganglioside/glycosphingolipid degradation is 
the splitting of the β-glucosidic linkage between glucose and ceramide, with the formation of 
ceramide and the oligosaccharide. The enzymes catalysing this reaction, named 
“endoglycoceramidases” or “ceramide glycanases” (154-159) appear to require, or to be 
markedly activated, by specific activator proteins whose action would be essential under in 
vivo conditions (154). Endoglycoceramidases have been found to occur in some bacteria 
(154) and leeches (155). Although described to occur in lactating mammary glands of 
rodents (157), the presence of this enzyme in vertebrate and, particularly, mammalian 
tissues is yet to be definitely assessed. 
For the non-glycosylated sphingolipids, like ceramide and SM, non-lysosomal degradation 
steps are known which apparently do not need the assistance of an activator protein. SM is 
cleaved to Ceramide and phosphorylcholine. Ceramide later on is degraded into sphingosine 
and a fatty acid by ceramidases of different subcellular localization. In the cytosol, 
sphingosine can be phosphorylated to sphingosine-1-phosphate or can be re-acylated to 
Ceramide. These highly regulated degradation processes occur at several subcellular places 
to produce various signal molecules (132, 160). Enzymes were also described that are 
capable to remove the fatty acid moiety from several sphingolipids (sphingomyelin, 
gangliosides and some neutral glycosphingolipids) producing the corresponding lyso-
derivatives (160, 161). These enzymes, known as sphingolipid ceramide N-deacylases, were 
detected in bacteria. No evidence was yet provided for their occurrence in vertebrates. 
However, it is known that in the brain of patients suffering from some sphingolipidoses 
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where there is accumulation of lyso-glycosphingolipids (162) these accumulated compounds 
seems to be the products of proteins having this kind of enzymatic activity. These products 
can leave the organelle and re-enter the biosynthetic pathway or serve as energy sources 
and be further degraded. 
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GLYCOHYDROLASES 
Glycohydrolases are a widespread group of enzymes involved in GSL metabolism, that 
hydrolyse the glycosidic bond between two or more carbohydrates, or between a 
carbohydrate and a non-carbohydrate moiety also called as glycosidases. The 
glycohydrolases are ubiquitous enzymes, being found in lysosomes, plasma membranes, 
cytosol and blood plasma (163-167). They are involved in the biosynthesis and degradation 
of glycogen in the body. Together with glycosyl transferases, glycosidases form the major 
catalytic machinery for the synthesis and breakage of glycosidic bonds. 
Glycohydrolases are found in essentially all domains of life. In bacteria and prokaryotes, they 
are found both as intracellular and extracellular enzymes largely involved in nutrient 
acquisition. One of the important occurrences of glycohydrolases in bacteria is the enzyme 
-galactosidase (LacZ), which is involved in regulation of expression of the Lac-operon in E. 
Coli. In higher organisms glycohydrolases are found within the endoplasmic reticulum and 
Golgi apparatus where they are involved in processing of N-linked glycoproteins, and in the 
lysosomes as enzymes involved in the degradation of carbohydrate structures. Deficiency in 
specific lysosomal glycohydrolases can lead to a range of lysosomal storage disorders that 
result in developmental problems or death. The glycohydrolases are involved in the 
biosynthesis and degradation of glycogen in the body. 
In each subcellular location glycohydrolases may be present in different forms, as shown by 
N-acetyl-L-D-glucosaminidase and sialidase (168, 169). The insertion of glycohydrolases into 
the plasma membrane is assumed to occur through a transmembrane hydrophobic domain. 
However, examples are known of other types of anchoring (170). 
Glycohydrolases are enzymes that catalyze the hydrolysis of O- or S-glycosides, they can also 
be classified according to the stereo chemical outcome of the hydrolysis reaction: thus they 
can be either retaining or inverting enzymes (171). Glycohydrolases can also be classified as 
exo- or endo- acting, dependent upon whether they act at the (usually non-reducing) end or 
in the middle, respectively, of an oligo/polysaccharide chain.  
Glycohydrolases may finally also be classified by sequence based methods. Sequence-based 
classifications are among the most powerful predictive method for suggesting function for 
newly sequenced enzymes for which function has not been biochemically demonstrated. A 
classification system for glycohydrolases, based on sequence similarity, has led to the 
definition of 85 different families (145, 172, 173). This classification is available on the CAZy 
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(Carbohydrate-Active EnZYmes) web site. The database provides a series of regularly 
updated sequence based classification that allow reliable prediction of mechanism 
(retaining/inverting), active site residues and possible substrates. Based on three 
dimensional structural similarities, the sequence-based families have been classified into 
'clans' of related structure. Recent progresses in glycosidase sequence analysis and 3D 
structure comparison have allowed the proposal of an extended hierarchical classification of 
the glycohydrolases. 
 
THE REGULATION OF GSL COMPOSITION AT THE PLASMA 
MEMBRANE 
Changes in the GSL composition of the plasma membrane in a certain cell type would lead to 
very important biological consequences, thus all mechanisms possibly contributing to these 
changes have a high functional significance. The classical view on sphingolipid metabolism 
implies the vescicular transport of neo-biosynthesized sphingolipids from the endoplasmic 
reticulum and the Golgi apparatus to the plasma membranes (reviewed in (174)). Changes in 
the activities of enzymes of the biosynthetic pathway have been associated with the changes 
in GSL expression that are correlated with biological events such as neoplastic 
transformation or neuronal differentiation. However, other mechanisms could be 
responsible for a local regulation of the GSL composition of plasma membranes or on 
restricted plasma membrane areas (Figure 16): 
1) Both catabolic and biosynthetic enzymes for sphingolipids have been found associated 
with the plasma membranes. “Signaling” sphingomyelinases are resident in or translocated 
to the plasma membrane, being able to convert plasma membrane sphingomyelin into 
ceramide (175, 176). Conversely, a plasma membrane-associated sphingomyelin synthase 
enzyme activity (SMS2), genetically distinct from the Golgi enzyme, has been identified 
(177). Thus, the sphingomyelin/ceramide ratio can be locally modulated possibly in response 
to physiological events, leading to profound consequence on the organization of 
sphingolipid-enriched membrane areas. In the case of GSL, a specific membrane-bound 
sialidase (Neu3) has been identified and cloned (93, 140, 141), and its role in modifying the 
ganglioside composition at the cell surface, acting as well on GSL molecules present on the 
surface of adjacent cells (i.e., in a “trans” fashion), has been proven (1, 178, 179). Moreover, 
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the presence of sialyltransferase activities at the cell surface has been also reported (180-
184). Thus, glycosylation/deglycosylation cycles might be very important mechanisms 
responsible for rapid and possibly transient changes of the plasma membrane GSL 
composition, in analogy to that proposed for the “sphingomyelin cycle”. The presence of 
other active glycohydrolases such as β-glucosidase, β-galactosidase and β-hexosaminidase 
(1, 185) in the plasma membrane has been demonstrated, implying that local hydrolysis of 
GSL at the cell surface might represent a general mechanism for the control of GSL 
composition.  
2) GSL can be released from the cell surface in different forms, including shedding vesicles 
(186-188), whose controlled release from specific glycolipid-enriched membrane areas could 
represent a further way to modify the lipid membrane domain composition and 
organization. 
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MEMBRANE GLYCOHYDROLASES 
Plasma membrane glycoconjugates show changes during development and neoplastic 
transformation (189, 190) suggesting a specific role in cell–cell recognition. Glycosyl epitope 
changes include many different residues, such as GlcNAc, GalNAc in N-linked structures or 
sialyl residues in either protein N-linked, O-linked or lipid linked structures, so that cell 
surface glycohydrolases could be one of the natural candidate for plasma membrane 
glycosylation modification.  
For this reason, although in the past little attention was paid to glycohydrolases acting on 
cellular compartment different from lysosomes, there is now increasing interest on plasma 
membrane associated glycohydrolases because on this compartment they should be 
involved, together with glycosyltransferases, in GSL oligosaccharide modification processes 
regulating cell to cell and/or cell–environment interactions in both physiological and 
pathological mechanisms (179, 191, 192) . 
Glycohydrolases are the enzymes involved in GSL metabolism. The presence of 
glycohydrolases on the plasma membrane (PM), where they can be involved in the 
modifications of the cell surface GSLs or of glycoproteins, has been demonstred (3). This 
class of enzymes are taken into account as they can participate in the modulation of signal 
transduction process.  
Some of the plasma membrane associated glycohydrolases are identified and their activity 
has been studied for characterisation. They are 
 Hexosaminidase 
 Sialidase or Neuraminidase 
 -galactosidase 
 -glucosidase 
 Sphingomyelinase 
 
The presence of -hexosaminidase A in the external leaflet of PM has been demonstrated in 
cultured fibroblasts (185). Immunological and biochemical characterization of the 
membrane-associated -hexosaminidase indicated that this enzyme has the same structure 
of that in lysosomes.  
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The linkage of sialic acid in sialic acid containing molecules is hydrolyzed by several different 
sialidases. Taking in account all the available data, Neu3 can be considered an ubiquitous 
enzyme being expressed at different levels in all the plasma membrane of tested normal and 
pathological human tissues such as human brain (95) normal and colon rectal carcinoma 
tissue, hepatic tumor and kidney carcinoma (193-197). In addition its expression and activity 
were also found in normal and pathological cell lines such as erytroid and erytroleukemic 
cells (198-200), human fibroblasts (201), rat and mouse neurons, neuroblastoma cells (202), 
human breast ductal cancer T47D cells, colon carcinoma CaCo2 cells, human colorectal 
adenocarcinoma HT29 cells, different type of ovarian cancer cells, human cervix 
adenocarcinoma HeLa cells. (197)  
An increase of Neu3 activity modifies the cell surface ganglioside composition by shifting 
Gg4 and Gg3 polysialylated species to monosialoderivatives, and GM3 to lactosylceramide, 
with deep consequences on neuronal differentiation and apoptosis in normal and 
pathological cells (1, 197, 203). In cultured hippocampal neurons, the activity of Neu3 locally 
regulated GM1 surface levels, and was essential for axonal growth and regeneration after 
axotomy (98). Neu3 and gangliosides co-localize in lipid rafts (178). The non-random 
distribution of Neu3 at the cellular surface introduces the possibility that the biological 
effects of this enzyme might be due to the local reorganization of glycosphingolipid-based 
signalling units. Remarkably, Neu3 is capable to modulate the cell surface glycolipid 
composition because of trans interactions, thus modifying the surface of neighboring cells 
(179). 
Plasma membrane associated -galactosidase has been found in all cell lines we studied for 
the activity of Neu3. In human fibroblasts its expression is up regulated by Neu3 (1). The -
galactosidase activity was measured during neuronal cell differentiation and aging, in the 
total cell lysate and in the plasma membranes from rat cerebellar granule cells. Both these 
activities resulted up regulated during cell differentiation. As expected the -galactosidase 
activity associated to the cell plasma membranes was much less than that found in total cell 
homogenate. The total cell activity remained constant during differentiation, then increased 
4 fold along aging in culture. Instead, cell surface activity increased 10 fold during 
differentiation, to then duplicate during the neuronal senescence (204). -galactosidase 
activity has been proposed as senescent marker of different cell lines (205-208). The 
information on the behavior of plasma membrane associated enzyme in rat cerebellar 
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granule cells suggests that its activity could be used as a good marker for both neuronal 
differentiation and neuronal aging. The identity of the protein, or proteins, responsible for 
the -galactosidase activity present at the cell surface is still unknown, however in living 
human fibroblasts has been verified the presence of a -galactosidase activity which displays 
a trans activity, with no necessity of detergents or activator proteins, on lactosyl ceramide 
immobilized on cell culture plates, suggesting that on the cell surface is present at least an 
enzyme having a  -galactocerebrosidase-like activity (3). 
Concerning -glucosidase, at least three different enzymes have been described: a -
glucocerebrosidase (GBA1) sensitive to the inhibition of Conduritol B Epoxide (CBE) normally 
described associated to the lysosomes (209), a cytosolic -glucosidase (210) and a non-
lysosomal -glucosylceramidase (GBA2). GBA2 has been found associated to endosome 
vescicles or to the plasma membrane. It is insensitive to CBE whereas is specifically inhibited 
by N-(5-adamantane-1-yl-methoxy)pentyl)-deoxynojirimycin (AMP-DNM) (211, 212). 
Recently it has been described that a CBE-sensitive -glucosidase activity is present in the 
plasma membranes (3). Both CBE-sensitive and CBE-insensitive -glucosidase activities were 
found associated to the cell surface of rat cerebellar granule cells in culture, where they 
progressively increase along the differentiation and the aging process (204). 
Total -glucosidase activity associated to the plasma membranes of human living fibroblasts 
works on natural substrates in trans fashion (3) and the activity is connected to Neu3 
activity. In fact, in human fibroblasts overexpressing Neu3, the -glucosidase activity 
associated to the plasma membrane was much higher of that found in normal fibroblasts. 
Surprisingly this is mainly due to an up-regulation of the CBE-sensitive -glucosidase (3).  
Three different SMases are available in eukaryotic cells (213): secreted SMase, acid SMase 
and neutral SMase. Secreted SMase exerts its activity in the extracellular environment. Acid 
SMase are principally located in the lysosomes and few evidences reports about its 
association to PM. Neutral sphingomyelinase identify a family of different enzymes that 
catalyze the hydrolysis of SM into ceramide at pH 7.4 and are Mg2+-dependent enzymes. 
Among the three recently cloned mammalian N-SMases, only nSMase2 and nSMase3 display 
in vivo activity. nSMase3 is reported to localize to the endoplasmic reticulum and the Golgi 
compartment (214, 215) while the subcellular localization of nSMase2 remains not fully 
determined. nSMase2 was first described as a Golgi-associated protein potentially involved 
in the Golgi secretory vesicle trafficking (216), however other studies have indicated a PM 
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localization of overexpressed GFP-, FLAG- or V5-tagged-nSMase2 in various cancer cell lines 
(217-219). This enzyme is characterized by the presence of two palmitoylation sites that 
were reported to be important for PM localization (220). Furthermore, stimuli such as TNFα, 
H202 and cell confluence seemed  to induce nSMase2 translocation from the Golgi to PM 
lipid rafts (213). 
Therefore the glycohydrolitic enzymes, responsible for the catabolism of the sphingolipids, 
are not only recovered in the classical cellular compartment deputed to the catabolism (the 
lysosomes) but are also associated to other cellular district. In some case the same lysosomal 
enzyme has been found associated to other compartments, as is the case of the -
hexosaminidase A associated to the plasma membrane; in some others, enzymes codified by 
different genes have been found in different regions of the cell. This last is the case of the 
sialidases Neu2, Neu3 and Neu4 with respect to the lysosomal enzyme Neu1, or the case of 
the non-lysosomal -glucosylceramidase GBA2.  
Considering the presence of lysosomal glycohydrolases at the cell surface two aspects need 
to be clarified: how lysosomal deriving enzymes can reach the plasma membrane and how 
they can be active at the cell surface where the pH conditions are far from those of the 
lysosomes? It is known that a regulated fusion of lysosomes with the plasma membrane 
might represent a general mechanism of repairing for the plasma membrane (221), and 
could be responsible of the presence of lysosomal enzymes facing at the cell surface. 
However this enzymatic “translocation” could not be accidental and the fusion of lysosomal 
membranes with the plasma membrane could be the way for all the lysosomal glycolipid-
metabolizing enzymes to reach the cell surface where, together with specific and different 
membrane associated enzymes, play an active role in remodeling the glycolipid content and 
pattern of the external leaflet of the plasma membrane.  
At the cell surface the pH conditions are usually considered near to the neutrality, whereas 
the lysosomal pH is much more acidic. For some glycohydrolases described associated to the 
plasma membrane has been evaluated the optimum of pH to which they play their catalytic 
activity. Both the -hexosaminidase A and Neu3 (respectively codified by the same and by a 
different gene with respect to the corresponding lysosomal enzyme) has been found 
working in acidic condition (pH 4.5 and pH 4.2 respectively). This information suggests that 
modulation systems, capable to modify the pH conditions, even locally, could be present at 
the cell surface. One hypothesis for this theory may be the action of proton pumps present 
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at the plasma membrane level for which has already been demonstrated a role in the 
acidification of the tumor extracellular environment (222-224). 
 
TRANSPORTERS/EXCHANGERS PRESENT AT PM LEVEL  
The induction and maintenance of intracellular alkalization and its subsequent extracellular, 
interstitial acidosis on intratumoral dynamics have been repeatedly implicated as playing an 
essential, direct and pivotal role both in cell transformation as well as in the active 
progression and maintenance of the neoplastic process. Both in vitro cell-culture studies and 
in situ tumor spectroscopic studies utilizing the 31P isotope have reported that tumor cells 
have alkaline intracellular pH (pHi) values (7.2–7.7 compared with 6.99–7.20 in normal 
tissues) and acidic interstitial extracellular pH (pHe) values (6.2–6.8 compared with 7.3–7.4) 
(222). So, the tumor extracellular environment is more acidic than the intracellular 
environment, creating a reversed pH gradient across the cell membrane that increases as 
the tumor progresses and it is considered to be one of the main characteristics defining the 
molecular energetic of tumors, regardless of their pathology and genetic origins (225). There 
are now ample data demonstrating that the aberrant regulation of hydrogen ion dynamics 
(the lower the oxygen level, the more protons H+ accumulate) leading to this reversed 
proton gradient is driven by a series of proton export mechanism from blood vessels to the 
necrotic area that underlie the initiation and progression of the neoplastic process.  
Continual re-adjustment of the pHi is essential since a variation of 0.1 units can disrupt 
multiple biological functions including ATP production, protein synthesis, cell proliferation, 
migration and apoptosis through caspase activation. A variety of constitutively expressed 
membrane-associated systems are involved in the regulation of the pHi of all mammalian 
cells (Figure 17): 
 the family of growth factor-activated NHEs (9 isoforms), that are Na+/H+  exchangers, 
 the vacuolar-type H+-ATPase (V-ATPase), that requires ATP to actively extrude two 
H+, 
 the MCTs (MCT1, MCT2 and MCT4), that transport lactic acid bidirectionally, 
 the NA+-HCO3- co-transporters (NBCs) and the Cl--HCO3- exchangers (AEs) that, in the 
opposite direction to H+ extrusion, favour HCO3- influx and thus contribute to 
cytoplasmatic alkalinisation, 
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 the family of carbonic anhydrases (CAs) and particularly, the cytosolic CAII 
have been shown to play a key role in the regulation of the physiological pH by catalysing the 
hydration of carbon dioxide to protons and bicarbonate ions (226). 
 
 
 
THE Na+/H+ EXCHANGER NHE1 
The Na+/H+ exchanger NHE1 is a member of a family of secondary active acid extruders that 
mediates the 1:1 exchange of extracelluar sodium for intracellular protons across the cell 
membrane. Through NHE1 action, the inwardly directed sodium gradient can drive the uphill 
extrusion of protons, alkalinize intracellular pH (pHi) and acidify the extracellular pH (pHe). 
NHE1 is expressed ubiquitously in non-epithelial cells and on the basolateral membrane of 
epithelial cells. It is composed of 12 transmembrane segments and a long carboxy-terminal 
cytoplasmic tail that has a role in both its regulation and function (Figure 24). The first 
functions of NHE1 to be identified were its role in regulating pHi homeostasis, cell volume 
and proliferation in response to growth factor stimulation. One of the important features of 
NHE1 is its exquisite sensitivity to pHi. When pHi drops below a threshold level NHE1 is 
  Introduction 
 
42 
 
activated through an internal allosteric proton-binding regulatory site. This pHi sensitivity 
determines the activity set point of NHE1 (that is, the pHi at which NHE1 is quiescent) and, in 
normal cells, this set point is at the physiological, resting pHi. Neoplastic transformation 
increases the affinity of the proton-regulatory site, thereby increasing the sensitivity of NHE1 
to the normal pHi, constitutively activating it and raising pHi. NHE1 in tumor cells is always 
active and these cells can have pHi values as high as 7.7. Through binding to the actin-
binding protein VIL2 (villin 2, a member of the ezrin, radixin and moesin (ERM) family), NHE1 
can directly regulate cytoskeletal dynamics independently of its ion-transporting capabilities, 
which permits the separation of the downstream functions of NHE1 into two groups. The 
first consists of those regulated by its ion translocation (Figure 18a), the second consists of 
those regulated by its ability to directly bind the ERM family and regulate cortical 
cytoskeleton dynamics by anchoring the cortical cytoskeleton to the plasma membrane 
(Figure 18b). Recently, NHE1 was also proposed to be able to act as a scaffolding protein 
through its direct association with a number of signaling proteins. These three different 
modes of regulation make NHE1 an important membrane-bound integrator for many 
signaling networks and cellular processes (222). 
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CHEMICALS AND MATERIALS 
Commercial chemicals were of the highest purity available, common solvents were distilled 
before use and water was doubly distilled in a glass apparatus. Trypsin, KCl, reagents for cell 
culture, Conduritol B Epoxide (CBE), 5-(N-Ethyl-N-isopropyl)amiloride (EIPA) and 4-
Methylumbelliferyl--N-acetylglucosaminide (MUG) were from Sigma-Aldrich (St Louis, MO, 
USA). Basal Modified Eagle’s, Minimum Essential Medium with Earle’s Salt (MEM) Dulbecco 
Modified Eagle’s (DMEM) medium and fetal calf serum were purchased from EuroClone 
(Leeds, UK). The following primary antibodies have been used: rabbit polyclonal anti-MAP2 
(#4542), mouse monoclonal anti-TAU (#4019), rabbit polyclonal anti-PSD95 (#2507), rabbit 
polyclonal anti-Synapsin (#2312) from Cell Signaling Technology, Inc. (Danvers, MA, USA); 
mouse monoclonal anti-Neuroglycan C (N73720), mouse monoclonal anti-L1 (L30220) from 
BD Biosciences (San Jose, CA, USA), mouse monoclonal anti-β-actin (A5441) and mouse 
monoclonal anti-β-tubulin (T4026) from Sigma-Aldrich (St Louis, MO, USA). Rabbit polyclonal 
antibody to TAG-1 was kindly provided by Dr. Karagogeos (57). As secondary antibodies we 
used mouse (#7076) and rabbit (#7074) horseradish peroxidase-conjugate antibodies from 
Cell Signaling Technology, Inc. (Danvers, MA, USA). 
[1-3H]Sphingosine was prepared by specific chemical oxidation of the primary hydroxyl 
group of sphingosine followed by reduction with sodium boro[3H]hydride (radiochemical 
purity over 98%; specific radioactivity 2 Ci/mmol). 
GM1 was prepared by sialidase digestion of a bovine brain ganglioside mixture and purified 
(Acquotti et al. 1994). LacCer was prepared by acidic hydrolysis of GM1 followed by 
purification (Sonnino et al. 1978). GM3 was prepared from GM1 (227). [3-
3H(sphingosine)]LacCer (radiochemical purity over 99%, specific radioactivity 1.2 Ci/mmole), 
[3-3H(sphingosine)]GM3 (radiochemical purity 98%, specific radioactivity 1.2 Ci/mmole), and 
[3-3H(sphingosine)]GM1 (specific radioactivity, 2.3 Ci/mmole) used as substrates of 
enzymatic assays and as chromatographic standards were prepared as described (228). 
Highperformance silica gel thin-layer plates (HPTLC Kieselgel 60, 10 x10 cm) were purchased 
from Merck GmbH (Milan, Italy). AM-calcein was from Invitrogen (Carlsbad, CA, USA). Triton 
X-100 were from Merck (Darmstadt, Germany). 4-Methylumbelliferyl--D-
galactopyranoside (MUB-Gal), 4-Methylumbelliferyl--Dglucopyranoside (MUB-Glc) and 4-
Methylumbelliferone (MUB) were from Glycosynth (Warrington, UK). 4- Methylumbelliferyl-
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-N-acetylglucosaminide-6-sulphate (MUGS) was from Toronto Research Chemicals Inc. 
(North York, Ontario, CDN). 6-Hexadecanoylamino-4-methylumbelliferyl-phosphorylcholine 
(HMU-PC) was from Moscerdam Substrates (Oegstgeest, Netherlands). 
The N-(5-adamantane-1-yl-methoxy)pentyl-deoxynojirimycin (AMP-DNM), specific inhibitor 
for the non-lysosomal -glucosylceramidase (GBA2) was kindly provided by Dr. Aerts, 
University of Amsterdam (212). 
 
CELL CULTURES 
FIBROBLASTS 
Normal human skin fibroblasts were obtained by the punch technique from normal children 
(age 6-12 month), cultured and propagated as described (229) in 75-cm2 flask the enzymatic 
assays 96-wells microplate at a density of 24000 cells/well for the surface enzymatic assay, 
using Minimum Essential Medium with Earle’s Salt (EMEM) supplemented with 10% FBS, 1% 
Glutamine and 1% Pencilin/Streptomycin. 
 
NEURONAL GRANULE CELLS 
Granule cells, obtained from the cerebellum of 8-day-old Sprague-Dawley rats, were 
prepared and cultured as described (230). Cells were plated in 60-mm dishes at a density of 
3 x 10 6 cells/dish for the enzymatic assays on total homogenate or plated in 24-wells 
microplate at a density of 375000 cells/well for the surface enzymatic assay. In both cases 
cells were cultured with Basal Modified Eagle’s Medium (BME) containing 10% heat-
inactivated foetal calf serum. The animals were sacrificed by decapitation. 
 
PROTEIN ANALYSIS 
The amount of protein present in the cell lysates was determined by DC protein assay in 
according to the manufactures instructions.  
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ENZYMATIC ACTIVITIES AT THE CELL SURFACE 
PM ASSOCIATED SMase  
PM-associated SMase activity was determined in living fibroblasts plated in 96-wells 
microplate. The artificial substrate HMU-PC was solubilized in the medium at the final 
concentrations of 0.50 mM. Cell culture medium was removed and cells were washed with 
DMEM without phenol red. The artificial substrate solubilized in the opportune medium was 
then added to the cell monolayers and the incubation was performed at 37°C under very 
gently stirring. At different times (from 30 minutes to 1 hours) aliquots of the medium were 
fluorometrically analyzed adding 15 volumes of 0.25 M glycine, pH 10.7 and 0,2% Triton 
X100. 50 pmoles of Free Hexadecanoil-amino-MUB were used as standard. 
 
PM ASSOCIATED -Gal AND -Glc  
PM-associated -galactosidase and -glucosidase activities were determined in living cells 
plated in 96-wells microplate for fibroblasts and 24-wells microplate for neuronal granule 
cells. The artificial substrates MUB-Gal and MUB-Glc were solubilized in DMEM without 
phenol red at the final concentrations of 0.25 mM and 6 mM respectively. The pH of 
medium was differently adjusted at pH 5.1 for the -galactosidase assay, and at pH 6.3 and 
pH 5.7 for the activity assays of the two different -glucosidases, the CBE-sensitive -
glucosidase and the CBE insensitive -glucocerebrosidase GBA2 respectively. Cell culture 
medium was removed and cells were washed with DMEM without phenol red. For the CBE-
sensitive -glucosidase and GBA2 assays cells were pre-incubated for 30 minutes at room 
temperature with 5 nM AMP-DNM in DMEM, pH 6.3 and with 1 μM CBE in DMEM, pH 5.7 
respectively. The artificial substrates solubilized in the opportune medium were then added 
to the cell monolayers and the incubation was performed at 37°C under very gently stirring. 
At different times (from 30 minutes to 6 hours) aliquots of the medium were 
fluorometrically analyzed adding 15 volumes of 0.25 M glycine, pH 10.7. 100 pmoles of free 
MUB were used as standard.  
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PM ASSOCIATED -Hex  
PM-associated -hexosaminidase activity was determined in living fibroblasts plated in 96-
wells microplate. The artificial substrates MUG and MUGS were solubilized in DMEM 
without phenol red at the final concentrations of 3 mM. MUG is hydrolysed by both - and 
-subunits, while MUGS is hydrolysed exclusively by -subunit. Cell-conditioned medium 
was removed and cells were washed with DMEM. The artificial substrate solubilized in the 
opportune medium was then added to the cell monolayers and the incubation was 
performed at 37°C under very gently stirring. At different times (from 30 minutes to 90 
minutes) aliquots of the medium were fluorometrically analyzed adding 15 volumes of 0.25 
M glycine, pH 10.7. 100 pmoles of free MUB were used as standard.  
 
PM ASSOCIATED ENZYMES ACTIVITY AT DIFFERENT pH 
CONDITIONS 
PM associated activity for each enzyme was also determined at different pH conditions. 
The pH of DMEM without phenol red was adjusted respectively with HCl (in order to obtain 
media at pH 5.10, 5.45 5.70 and 6.20) and NaOH (in order to obtain media at pH 7.90 and 
8.40). Each assay was then performed as described above.  
 
ENZYMATIC ACTIVITIES ASSOCIATED TO THE MEDIUM 
MEDIUM ASSOCIATED SMase ACTIVITY 
SMase activity associated with the medium was determined on the fluorogenic substrate 
HMU-PC. Cells were incubated for 2 days in DMEM without phenol red. Aliquots of medium 
were transferred in a 96-well microplate to perform the enzymatic assays in triplicate. HMU-
PC was solubilized at a final concentration of 0.50 mM in McIlvaine Buffer (0.1 M Citrate/0.2 
M Phosphate) pH 4.0. The reaction mixtures were incubated at 37°C under gently shaking for 
3 hours. The developed fluorescence was detected at different times transferring 20l of the 
reaction mixtures in an opportune microplate and adding 280 l of 0.25 M glycine, pH 10.7. 
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The fluorescence was detected by a Victor microplate reader (Perkin Elmer). Any released 
enzymatic activity was not measured. 
 
MEDIUM ASSOCIATED-Gal AND -Glc ACTIVITY 
-galactosidase and -glucosidase activities associated with the medium were determined 
on the fluorogenic substrates MUB-Gal and MUB-Glc. Cells were incubated for 2 days in 
DMEM without phenol red. Aliquots of medium were transferred in a 96-well microplate to 
perform the enzymatic assays in triplicate. MUB-Gal and MUB-Glc were solubilized at the 
final concentrations of 0.25 mM in McIlvaine Buffer (0.1 M Citrate/0.2 M Phosphate) pH 4.0, 
whereas MUB-Glc was prepared at the final concentration of 6 mM in the same buffer at pH 
5.2. The reaction mixtures were incubated at 37°C under gently shaking for 3 hours. The 
developed fluorescence was detected at different times transferring 20l of the reaction 
mixtures in an opportune microplate and adding 280 l of 0.25 M glycine, pH 10.7. The 
fluorescence was detected by a Victor microplate reader (Perkin Elmer). Any released 
enzymatic activity was not measured. 
 
MEDIUM ASSOCIATED-Hex ACTIVITY  
-hexosaminidase activity associated with the medium was determined on the fluorogenic 
substrate MUG. Cells were incubated for 2 days in DMEM without phenol red. Aliquots of 
medium were transferred in a 96-well microplate to perform the enzymatic assays in 
triplicate. MUG was solubilized at a final concentration of 3 mM in McIlvaine Buffer (0.1 M 
Citrate/0.2 M Phosphate) pH 5.0. The reaction mixtures were incubated at 37°C under gently 
shaking for 3 hours. The developed fluorescence was detected at different times transferring 
20l of the reaction mixtures in an opportune microplate and adding 280 l of 0.25 M 
glycine, pH 10.7. The fluorescence was detected by a Victor microplate reader (Perkin 
Elmer). Any released enzymatic activity was not measured. 
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NEU3 ACTIVITY ASSAY 
Neu3 enzyme activity was evaluated using GM3 as substrate. 20 l of cellular homogenate 
were incubated with Na-acetate buffer 100mM, pH 4.5, Triton X100 0,04%, 6 M [3H]GM3, 
final volume 50 l. Final concentration of GM3 in micelles is 6M containing 5000 dpm of 
[3H]GM3 labeled with [1-3H] Sphingosine. Buffer and homogenate incubation is made at 
37°C under shaking (800 rpm) for 2 hours. at the end of the incubation the reaction is 
blocked with 1,5 ml chloroform/methanol. 
 
ENZIMATIC ACTIVITIES IN CELL HOMOGENATE 
ST ACTIVITY ASSAY  
ST-I activity was assayed on neuronal cell homogenates using [3-3H(sphingosine)]LacCer as 
substrate(228). ST-II and ST-IV activities were measured as previously described (231) using 
[3-3H(sphingosine)]GM3 and [3-3H(sphingosine)]GM1 as substrates. The enzymatic reactions 
of different sialyltransferases were stopped by adding chloroform/methanol (2:1) and 
analyzed by HPTLC using the solvent system 55:45:10 chloroform/methanol/0.2% aqueous 
CaCl2. Separated radioactive lipids were detected and quantified by radioactivity imaging 
performed with a Beta-Imager 2000 instrument (Biospace, Paris, France) and the 
radioactivity associated with individual lipids was determined with the specific -Vision 
software provided by Biospace.  
 
SIALIDASE ACTIVITY ASSAY  
Total sialidase activity was determined on neuronal cell homogenates with 2'-(4-
methylumbelliferyl)--D-N-acetylneuraminic acid sodium salt hydrate as a substrate (201). 
Assays were performed in triplicate. Negative controls for all the assays were performed 
using heat-inactivated cell homogenates (100°C for 3 minutes). Data were expressed as 
pmoles of converted substrate/106 cells x h and are the means ± SD of three independent 
experiments.  
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-Gal AND -Glc ACTIVITY ASSAY  
In neurons -galactosidase and -glucosidase activities associated with total cell 
homogenates were determined on the fluorogenic substrates: MUB-Gal and MUB-Glc. 
Briefly, cells were washed twice with PBS, harvested and resuspended in water for the -
glucosidase assay, and in 0.2% Triton X-100 for the -galactosidase assay. Aliquots of cell 
homogenate were transferred in a 96-well microplate to perform the enzymatic assays in 
triplicate. MUB-Gal was solubilized at a final concentration of 0.25 mM in McIlvaine Buffer 
(0.1 M Citrate/0.2 M Phosphate) pH 4.0, whereas MUB-Glc was prepared at the final 
concentration of 6 mM in the same buffer at pH 5.2. The reaction mixtures were incubated 
at 37°C under gently shaking. The developed fluorescence was detected at different times 
transferring 20l of the reaction mixtures in an opportune microplate and adding 280 l of 
0.25 M glycine, pH 10.7. The fluorescence was detected by a Victor microplate reader 
(Perkin Elmer). Data were expressed as pmoles of converted substrate/106 cell x h and are 
the means ± SD of three independent experiments.  
 
MODIFICATION OF THE ACTIVITY OF PROTON PUMPS USING 
EIPA 
The activity of the proton pumps was modified using EIPA at two different concentrations 
(0,1 M and 1 M). EIPA was solubilized in DMEM without phenol red medium at pH 7.3. 
Cells were pre-incubated at room temperature for 30 minutes and then we performed the 
different enzymatic activity assay on the PM as above with the only difference of the 
presence of EIPA also during the assay. 
 
CELL VIABILITY DETERMINATION 
The cell viability and membrane integrity of granular cells used for cell surface enzymatic 
assays were determined using both AM-Calcein staining and Trypan-blue exclusion method. 
For the calcein staining cells were washed with PBS, the plate was then put on ice and 200 μl 
of calcein (6.25 μg/ml in PBS) were added to each well. Cells were incubated for 15 minutes 
at 37°C, 5% CO2. Calcein is then removed and to each well 100 μl of PBS and 50 μl of 1% 
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Triton X-100 were added. Plate was stirred at room temperature for 15 minutes and then 
the fluorescence was detected by a Victor microplate reader (Perkin Elmer). 
 
SDS-ZYMOGRAPHY 
Culture media  were thawed in ice and mixed 3:1 with sample buffer (containing 10% SDS). 
Samples (15 g of total protein per sample) were run under non-reducing conditions without 
heat denaturation onto 10% polyacrylamide gel (SDS-PAGE) co-polymerized with 1 mg/ml of 
type I gelatin. The gels were run at 4°C. After SDS-PAGE, the gels were washed twice in 2.5% 
Triton X-100 for 30 min each and incubated overnight in a substrate buffer at 37°C (Tris-HCl 
50 mM, CaCl2 5 mM, NaN3 0.02%, pH 7.5). The matrix metalloproteinase (MMP) gelatinolytic 
activity was detected after staining the gels with Coomassie brilliant blue R250, as clear 
bands on a blue background. Lysis bands were quantified by densitometric scanning (UV 
Band, Eppendorf). 
 
CELL LIPIDS ANALYSIS 
Neuronal granule cells (2nd, 8th and at the 17th day in culture) were incubated in the presence 
of 3 × 10−8 M [1-3H] Sphingosine. After 2 hours of pulse the medium was removed and 
replaced with fresh medium without radioactive sphingosine for fibroblasts and with cell-
conditionated medium for granule cells. Then, cells were incubated for 48 h of chase. Under 
these conditions, free radioactive sphingosine was hardly detectable in the cells, and all 
sphingolipids and phosphatidylethanolamine (obtained by recycling of radioactive 
ethanolamine formed in the catabolism of [1-3H]sphingosine) were metabolically 
radiolabeled (232, 233). 
Cells were harvested in ice-cold water (2 ml) by scraping with a rubber policeman, and 
lyophilized. Lipids were extracted twice with chloroform/methanol/water 2:1:01 by volume 
(first extraction, 1.5 ml; second extraction, 0.25 ml). Lipids were separated by 
monodimensional HPTLC carried out with the solvent systems chloroform/methanol/0.2% 
aqueous CaCl2, 50:42:11 or 55:45:10 (v/v). The identity of radioactive lipids was assessed by 
comparison with standard lipids. 
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WESTERN BLOT ANALYSIS 
The same amount of proteins derived from the cell lysates obtained from neural granule 
cells at different days were analysed by the SDS-PAGE and, after separation, proteins were 
transferred to PVDF membranes. The presence of MAP2, TAU, Tag-1, L1, Synapsin, 
Neuroglycan C and PSD95 was assessed using the specific primary antibody antibodies and 
the opportune horseradish peroxidase-conjugate secondary antibodies. -actin and -
tubulin were used as loading control. The antibody staining was followed by enhanced 
chemiluminescence detection (PierceSupersignal). The data acquisition was performed using 
a GS-700 Imaging Densitometer (Bio-Rad).  
 
OTHER ANALYTICAL METHODS 
The radioactivity associated with lipids was determined by liquid scintillation counting. 
Digital autoradiography of the HPTLC plates was performed with a Beta-Imager 2000 
instrument (Biospace, Paris) using an acquisition time of about 24 hours. The radioactivity 
associated with individual lipids was determined with the specific β-Vision software provided 
by Biospace. Protein content was determined according to Lowry (234) using bovine serum 
albumin as reference standard.  
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EVALUATION OF THE PM-ASSOCIATED ENZYME ACTIVITY 
Previous studies have demonstrated the presence at PM level of glycohydrolases involved in 
a complex network of metabolic pathways (1, 3, 235). Therefore, it was decided to set up a 
new method simpler respect the ones used in the previous experiments. 
Using human fibroblasts, it was set up an HTA (high throughput assay) method able to 
measure the activity of -galactosidase, CBE sensitive -glucosidase, GBA2 -glucosidase, 
SMase and -hexosaminidases, enzymes working directly at the plasma membrane level 
using MUB derivates as substrate (Table 1) The substrates were solubilized in cell culture 
medium at pH 7.3 without serum and phenol red and then added to a fibroblasts monolayer.  
In order to discriminate between the CBE-sensitive -glucosidase and the -glucosidase 
GBA2, cells were pre-treated with 5nM N-(5.adamantane-1-yl-methoxy)pentyl-
deoxynojirimycin or 1 M CBE respectively for 30 minutes at room temperature and then 
the enzymatic assays were performed as well in presence of these inhibitors.  
After 30 minutes up to 6 hours of incubation at 37°C the fluorescence associated to the cell 
and the medium was detected by fluorimeter (Figure 19).  
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ENZYME ARTIFICIAL SUBSTRATE 
Sphingomyelinase (SMase) 
-Hexadecanoylamino-4-methylumbelliferyl-
phosphorylcholine (HMU-PC) 
-Galactosidase -Gal) 
4-Methylumbelliferyl--D-galactopyranoside 
(MUB-Gal) 
CBE-sensitive -glucosidase 
4-Methylumbelliferyl--D-glucopyranoside 
(MUB-Glc) 
+ 
N-(5-adamantane-1-yl-
methoxy)pentyldeoxynojirimycin (AMP-DNM) 
CBE insensitive -glucocerebrosidase GBA2 
4-Methylumbelliferyl--D-glucopyranoside 
(MUB-Glc) 
+ 
Conduritol B Epoxide (CBE) 
Hexosaminidase-Hex) 
4-Methylumbelliferyl--N-acetylglucosaminide 
(MUG) 
Hexosaminidase A (-Hex A) 
4- Methylumbelliferyl--N-
acetylglucosaminide-6-sulphate (MUGS) 
 
Tab. 1: identification of the appropriate artificial substrate used to evaluate the activity 
of each enzyme. 
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It was verified that even in this situation the HTA method provides information on the 
activities of only plasma membrane associated enzymes (Table 2).  
 
ENZYME ACTIVITY  
SMase 579,955 ± 4,794 pmoli/(106cells*h) 
-Galactosidase  132,11 ± 32,427 pmoli/(106cells*h) 
CBE-sensitive -glucosidase 2730 ± 129,583 pmoli/(106cells*h) 
CBE insensitive -glucocerebrosidase GBA2 515,5 ± 29,817 pmoli/(106cells*h) 
Hexosaminidase 47,625 ± 6,168 nmoli/(106cells*h) 
Hexosaminidase A  7,528 ± 2,265 nmoli/(106cells*h) 
 
Tab. 2: evaluation of the activity of each enzyme. 
 
Besides, it was proved that the fluorigenic substrates does not have intracellular catabolism 
because no fluorescence has been found in the cell lysate of fibroblasts on such as the HTS 
was performed. In addition, it was verified that there is not an unusual fusion of lysosomes 
with the plasma membrane as a result of changes in extracellular pH as described on human 
breast cancer cells (236). Cells were incubated over night in their media (at different pH, as 
described above) and an experiment of enzymatic activity was subsequently conduced using 
each substrate described above: it was obtained as result the lack of enzymatic activity and 
this clearly highlights the fact that there is not any activity released (data not shown). 
Moreover, in order to study more thoroughly the matter of pH dependent lysosomal fusion 
with the PM, using the same media in which released activity were verified, zymography 
experiments were lead. This experiment showed that in these cells, at HTA experimental 
conditions, is not observed any increased release of MMP2 (a typical matrix 
metalloproteinase released in the extracellular environment by the lysosomal fusion with 
the PM) in no one of the tested media. This indicates, on one hand, the maintenance of 
constant lysosomal fusion, on the other, that this fusion not influenced by the extracellular 
pH.  
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Therefore we started to characterize the kinetic parameters evaluating the best pH 
conditions to obtain the maximum activity of each enzymes using the appropriate artificial 
substrate using as cellular model human fibroblast in culture.  
The optimum pH working condition of each enzyme was established performing a HTA assay 
using solubilized substrates in cell cultured medium without serum and phenol red at 
different pH: 
 5.10 
 5.45 
 5.70 
 6.20 
 7.30 
 7.90  
 8.40 
 
Thus we determined the optimum pH condition for each enzyme: SMase (Figure 20), -
galactosidase (Figure 21), -hexosaminidase (Figure 24) and -hexosaminidase A (Figure 25) 
show the maximum activity at pH 5.10 ,whereas CBE sensitive -glucosidaseat pH 6.20 
(Figure 22) and GBA2 -glucosidase at pH 5.7 (Figure 23). 
 
By calcein staining and Trypan blue exclusion method it was found that cells at different pH 
had the same proliferation and viability . 
 
The data are expressed as pmoles/(106 cells x h) the date are strictly associated to the 
substrate concentration for this reason the activity are relative and not absolute. Data are 
the mean ± SD of three different experiments. Statistical significance of differences was 
determined by Student’s t-test and Two-way ANOVA. *p < 0.005 of the activity measured 
versus the activity measured at different pH 
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DETERMINATION OF Vmax AND Km DIRECTLY ON EXTERNAL 
LEAFLET OF THE PM OF LIVING CELLS 
After we estabilished the optimum of pH of each enzyme we were able to determine the Km 
and the Vmax of the CBE-sensitive -glucosidase (Figure 26) and GBA2 -glucosidase (Figure 
27). 
 
CBE-sensitive -glucosidase 
The experiment was carried out evaluating the reaction at growing substrate concentration. 
As it can be seen the kinetics has an hyperbolic trend (Figure 26a) and it was possible to 
calculate the value of Km (3,313 mM) and Vmax (0,2965 pmol/min) by Lineweaver-Burk 
graph (Figure 26b). 
 
GBA2 -glucosidase 
The experiment was carried out evaluating the reaction at growing substrate concentration. 
As it can be seen the kinetics has an hyperbolic trend (Figure 27a) and it was possible to 
calculate the value of Km (2,435 mM) and Vmax (0,05560 pmol/min) by Lineweaver-Burk 
graph (Figure 27b). 
 
At the end of the experiments we evaluated by calcein staining and Trypan blue exclusion 
method, it was evaluated that cells in both experiments had the same proliferation and 
viability indicating the absence of substrate toxicity. 
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DETERMINATION OF ENZYME ACTIVITY AFTER 
ADMINISTRATION OF NHEs INHIBITOR (EIPA) 
In the previous paragraph it was found that the plasma membrane associated enzymes 
shows acidic pH as best pH working conditions, this can be considered strange being this 
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enzymes associated to the plasma membrane whose pH is usually defined neutral. However 
in the plasma membrane there are different proton pump that could locally shift the neutral 
pH to acidic pH. In fact at least 7 different families of transporters/exchangers are present at 
this level and are capable of varying the pH locally. In order to verify whether the varying of 
the membrane potential acting on these pumps can influence also the activity of these 
enzymes, we carried out preliminary experiments using 5-(N-Ethyl-N-isopropyl)amiloride 
(EIPA), an inhibitor of NHEs (Na+/H+) exchangers solubilized together with appropriate 
fluorigenic substrates in cell culture medium without phenol red and serum at pH 7.4. As 
control we used cells without EIPA incubation.  
We determined the activity of -galactosidase (Figure 28), CBE sensitive -glucosidase 
(Figure 29), GBA2 -glucosidase (Figure 30), -hexosaminidase (Figure 31) and -
hexosaminidase A (Figure 32) after administration of EIPA at two different concentrations: 
 
 0,1 M 
 1 M 
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As it can be seen in the graphs EIPA 0,1 M doesn’t affect the activity of the enzyme.  
EIPA 1 M contrariwise, on the one hand is able to decrease the activity of -galactosidase 
(Figure 28), CBE sensitive -glucosidase (Figure 29) and GBA2 -glucosidase (Figure 30), on 
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the other it doesn’t have any effect on the activity of -hexosaminidase (Figure 31) and -
hexosaminidase A (Figure 32). This could be due to a different localization of these two 
enzymes on the plasma membrane respect to the others above. So, EIPA 1 M seems to be 
able to modulate the activity of NHEs (Na+/H+) exchangers present in some areas of the PM 
with the following variation of the pH and the modulation of the enzyme activities. 
At the end of the experiment it was evaluated, by calcein staining and Trypan blue exclusion 
method, that cells in all experiments had the same proliferation and viability indicating that 
EIPA is not toxic. 
The data are expressed as pmoles/(106 cells x h) and are the mean ± SD of three different 
experiments.  
 
GLYCOHYDROLASES ACTIVITY DURING IN VITRO NEURONAL 
DIFFERENTIATION OF RAT CEREBELLAR GRANULE CELLS 
After a partially characterization of these PM-associated glycohydrolases we start to 
investigate about their functional role during the cell live and in particular we focused our 
attention to study their involvement during the neuronal differentiation. As well known from 
the literature during the neuronal differentiation the glycosphingolipid content and pattern 
underwent to a strong remodelling. For these reasons we think that this could be a good 
starting point to study the involvement of the PM glycohydrolases in cell physiology. 
 
CHARACTERIZATION OF THE RAT CEREBELLAR GRANULE CELLS 
DEVELOPMENT in vitro 
Cerebellar granule cells were prepared from 8-day-old Sprague–Dawley rats, and allowed to 
differentiate in vitro. These cells immediately start to differentiate and spontaneously 
undergo a developmental pattern that resembles the one of cerebellar neurons in vivo, but 
in a condensed time scale, reaching fully differentiated state after 8 days. During in vitro 
development it was observed the formation of an important net of neurites and the 
establishment of synapses which are made possible by the production of new specialized 
membrane, in fact all these events are accompanied by dramatic changes in the lipid content 
and pattern (56).  
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Glycerophospholipids and cholesterol, that represent the bulk of membrane lipids, 
significantly increase within the days in culture, maintaining however a very similar pattern 
during cell differentiation (data not shown).  
Sphingolipid content underwent a marked increase during neuronal development. Along the 
days in culture, cell morphology (Figure 33a), expression of specific proteins (Figure 33b), 
and sphingolipid patterns (Figure 33c) were determined to confirm neuronal development 
and aging.  
Rat cerebellar granule cells at the 2nd day in culture already emit short neurite-like processes. 
At the 8th day in culture cells are mostly grouped in large aggregates connected by an 
important net of neurites. This morphology is emphasized with the cell aging and, at the 17th 
day in culture, the cell bodies are organized in very big clumps connected by bundles of 
fasciculate neuritis (Figure 33a). 
The microtubule associated protein MAP2, a neuronal marker typically associated to 
dendrites, is present in the isoforms of 80 and 280 kDa (237-239) and its content reached 
the maximum level between the 7th and 9th day in culture, whereas it is possible to observe 
a down–regulation in aged cells. A similar expression pattern could be observed for low 
molecular weight Tau proteins, a microtubule associated proteins which promote process 
formation in neurons and are preferentially targeted in axons of the CNS neurons (239, 240). 
As already reported for other neuronal cell cultures, TAG-1, a glycoprotein responsible for 
the axon extension, showed the maximum expression at the earliest stages of differentiation 
and gradually reduced during the days in culture. On the other hand, L1 that is involved in 
the onset of axon fasciculation (observed in these cells after the 8th day in culture) showed 
an opposite behavior, reaching the maximum expression during the cell aging (241-245). 
Synapsin, Neuroglycan C and Post Synaptic Density protein 95 (PSD95) are typical synaptic 
markers (246-250). Their expression in rat cerebellar granule cells appeared very similar, 
being almost undetectable at the first days in culture whereas their content increase from 
the 7th day in culture and remained high even in senescent neurons (Figure 33b). 
The analysis of the sphingolipid pattern was performed on the total cell lysates obtained 
from cells at the 2nd, 8th and 17th day in culture by steady-state metabolic labeling using [1-
3H]sphingosine. Data obtained (Figure 33c) were in accordance to those already published 
(56). 
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ENZYMATIC ACTIVITIES IN TOTAL CELL HOMOGENATE 
The activities of the sialyltransferases ST-I, ST-II and ST-IV, were evaluated in the total cell 
lysates of granular cells at different day in culture. In agreement with previous data, 
obtained from human brain development (54, 251), it was found that the activities of ST-I 
and ST-IV increased during the neuronal differentiation. In addition, also the activity of ST-II 
increased in an in vitro assay (Figure 34). 
The up-regulated ST-I activity did not produce an increase of the GM3 content. This is 
probably due to the rapid synthesis of more complex gangliosides from GM3 by ST-II and ST-
IV. ST-II acts on the GM3 to produce GD3 whose endogenous content, referred to the cell 
number, increases 4 fold during cell differentiation even if the highest percentage of 
radioactive GD3 is at the 2nd day in culture. The absence of correlation between endogenous 
content and the radioactivity incorporation for GM3 and GD3 at the 2nd day in culture is due 
to the rapid turnover of these species at the first stages of neural differentiation (56). At the 
same time the increased activities of UDP-GalNac: LacCer/GM3/GD3/GT3 β1-4 N-
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acetylgalactosaminyltransferase and UDP-galactose: GA1/GM1/GD1b/GT1c β1-4 
galactosyltransferase (252) subtract GM3 for the synthesis of GM1 and ST-IV allows the 
synthesis of GD1a from GM1. The same enzymes can lead to the gangliosides of the b-series 
from GD3.  
During cell aging the total cell ganglioside content does not change, while the 
sialyltransferase activities underwent to a decrease, particularly ST-I and ST-IV. This could be 
explained by the strong reduction in the gangliosides turnover in senescent neurons (56). 
Figure 35 shows the activities in total cell homogenates of sialidase, -galactosidase and -
glucosidase. The sialidase activity in total cell homogenate is mainly due to the activity of the 
lysosomal sialidase Neu1, whose activity strongly increased during neuronal differentiation 
whereas it did not significantly change in neuronal aging. A similar trend was observed for 
the activity of total cell -glucosidase. Several papers reported about the role of this enzyme 
in the regulation of the number of axonal branches and length of axonal plexus (253). The 
activity of total -galactosidase did not increase during neuronal differentiation whereas it is 
possible to observe a 4 fold increase during the cell aging. This is in agreement with what 
already presented (102) on the increased activity of a “senescence-associated -
galactosidase” in aging hippocampal neurons. 
 
The data are expressed as pmoles/(106 cells x h) and are the mean ± SD of three different 
experiments. Statistical significance of differences was determined by Student’s t-test and 
Two-way ANOVA. *p < 0.005 of the 8th day activity versus the activity measured at the 2nd 
day in culture. #p<0.005 of the activity measured at the 17th day in culture versus that 
measured at the 8th day.  
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ENZYMATIC ACTIVITIES AT THE CELL SURFACE 
Behind to the evaluation of the total cell activity of the principal glycohydrolases involved in 
the glycosphingolipid catabolism it was measured, using HTA, also the PM-associated activity 
during the rat granular cells in vitro differentiation. Each enzymatic activity was performed 
directly using optimum pH working condition (pH 5.10 for -galactosidase, pH 5.7 for GBA2 
-glucosidase and pH 6.20 for CBE sensitive -glucosidase). By calcein staining and Trypan 
blue exclusion method it was found that the treatments were no toxic for cells. It was found 
that sialidase Neu3 (Figure 36) reached the maximum activity at day 8th in culture 
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corresponding to the fully differentiated neuronal stage, and partially decreased during 
aging. As shown in figure 37, along cell differentiation in culture, it was measured -
galactosidase (Figure 37a), CBE-sensitive -glucosidase and non-lysosomal -glucosidase 
GBA2 activities (Figure 37b). As expected, the PM-associated activity of these enzymes was 
very low with respect to the corresponding activity found in the total cell homogenates. 
Differently to what observed for the total -galactosidase, whose activity did not change 
along cell differentiation in culture, and increased 4 fold during aging, the -galactosidase 
activity associated with the cell surface underwent to a gradual and strong (20 fold from the 
2nd to the 17th day in culture) increase during both differentiation and aging. These results 
can suggest that both total cell -galactosidase and PM -galactosidase could be considered 
markers of senescence. The -glucosidase activity at the cell surface increased during the 
different days in culture and this was mainly due to the non-lysosomal -glucosidase GBA2 
that reached a peak of activity during the cell aging (Figure 37b). 
 
By calcein staining and Trypan blue exclusion method it was found that 90-95% of cells used 
for the cell surface enzymatic assays were alive and the membrane integrity were 
maintained.  
 
In order to discriminate between the CBE-sensitive -glucosidase and the non-lysosomal -
glucosidase GBA2, cells were pre-treated with 5nM N-(5.adamantane-1-yl-methoxy)pentyl-
deoxynojirimycin or 1 M CBE respectively for 30 minutes at room temperature and then 
the enzymatic assays were performed as well in presence of these inhibitors. The data are 
expressed as pmoles/(106 cells x h) and are the mean ± SD of three different experiments. 
Statistical significance of differences was determined by Student’s t-test and Two-way 
ANOVA. *p < 0.005 of the activity measured versus the activity measured the previous day. 
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Glycosphingolipids are components of the cell plasma membranes participating in the 
organization of lipid domains and modulating several aspects of the signal transduction 
processes (254). Plasma membranes glycosyl hydrolases (179, 185, 191, 192) seem to be the 
natural candidates for modifications of the cell surface glycolipids, taking part to the 
modulation of the signal transduction processes. Recent studies have demonstrate the 
presence of glycosyl hydrolases non only intrecellularly but also at plasma membrane level 
(1, 3, 185). Among membrane associated glycosyl hydrolases, the membrane bound sialidase 
Neu3 (1), SMase, -galctosidase, -glucosidase (3) and -hexosaminidase (185) have been 
characterized. Neu3, together with plasma membrane-associated -galactosidase and -
glucosidase, participates to the production of bioactive ceramide at the cell surface of 
human fibroblasts in culture (1). The structure of the plasma membrane-associated -
galactosidase is still unknown; it could be the lysosomal enzyme transferred to the plasma 
membrane during a cell surface repairing process by fusion of lysosomes with plasma 
membranes (221). Three different SMases are available in eukaryotic cells (255): secreted 
SMase, acid SMase and neutral SMase. Secreted SMase exerts its activity in the extracellular 
environment. Acid SMase are principally located in the lysosomes and few evidences reports 
about its association to PM. Neutral sphingomyelinase identify a family of different enzymes 
that catalyze the hydrolysis of SM into ceramide at pH 7.4 and are Mg2+-dependent enzymes. 
Two distinct -glucosidases are associated with the plasma membranes of fibroblasts. One 
enzyme could derive from lysosomes (CBE sensitive -glucosidase), but the other is the 
known as GBA2 -glucosidase, displaying a structure different from that of lysosomes 
(256).The expression levels of the three plasma membrane-associated enzymes Neu3, -
galactosidase and -glucosidase are interdependent and affected by those of other enzymes 
of glycosphingolipid metabolism. As for Neu3, plasma membrane -galactosidase and -
glucosidase display trans activity in living cells being capable to act on substrates belonging 
to neighboring membranes with no addition of activator proteins or detergents (3). The 
presence of -hexosaminidase A protein in the external leaflet of plasma membrane has 
been also demonstrated in cultured fibroblasts (185). The membrane protein shows in vitro 
enzymatic activity on artificial substrates and on natural glycolipids in the presence of GM2 
activator protein. Immunological and biochemical characterization of the membrane-
associated -hexosaminidase A indicated that this enzyme has the same structure of the 
lysosomal enzyme. As demonstrated by different scientist (221, 257) a general mechanism to 
  Discussion 
76 
 
repair the plasma membrane torn is represented by the fusion of lysosomes membrane. This 
event could be the way for all the lysosomal glycolipid-metabolizing enzymes to reach the 
cell surface where they play an active role in remodeling the glycolipid composition together 
with specific and different membrane-associated enzymes (235). 
During my thesis periods, I set up an HTA (high throughput assay) method able to measure 
the activity of SMase,-galactosidase, CBE sensitive -glucosidase, GBA2 -glucosidase and 
-hexosaminidases, enzymes working directly at the plasma membrane level of human 
fibroblast in culture using MUB derivates as substrate. Afterwards we applied this assays in 
order to study these PM associated activities in rat cerebellar granule cells along 
differentiation and aging in culture. Up to now the assay used to mesure the activity of these 
enzymes was a cell free assay based on the isolation of PM proteins by surface biotinylation 
followed by streptavidin affinity chromatography. PM associated activities were evaluated 
by in vitro assays using the fractions containing the PM proteins but, recently, we have 
developed this method capable to evaluate the activity of enzymes involved in the 
sphingolipids metabolism directly on the plasma membrane of living cells (in vivo) (2). 
So, I set up an high trough put assay for the detection of cell surface SMase,-galactosidase, 
-glucosidase and -hexosaminidases activities using fluorigenic artificial substrates that are: 
HMU-PC to detect SMase activity, MUB-Gal for -galactosidase and MUB-Glc in presence of 
5 nM AMP-DNM, that is a specific inhibitor of GBA2 -glucosidase, in order to detect the 
lysosomal -glucosidase activity whereas, to detect GBA2 -glucosidase activity, we used 
MUB-Glc in presence of 1 M CBE, that is a specific inhibitor of CBE sensitive -glucosidase 
(Table 1). Finally we used MUG to detect -hexosaminidase activity and MUGS for -
hexosaminidase A. The substrates were solubilized in cell culture medium without serum 
and phenol red and then added to a fibroblast monolayer. After one or more hours of 
incubation at 37°C the fluorescence associated to the cell and to the medium was detected 
by fluorimeter. No fluorescence was found associated to cell homogenates, this means that 
artificial substrates do not enter into the cells, whereas we found fluorescence associated to 
the medium. So, we verified that the fluorescence detected in the cell medium was not due 
to a release of the enzyme during the assay, so the measured activity was really due to the 
enzymes present at the cell surface (data not shown).  
Using this methods we stating to characterize some characteristic parameter of this enzymes 
when they work in living cell using human fibroblast as cellular model. First of all I 
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characterized the best pH working condition for each PM-associated enzyme. SMase shows 
the highest activity at pH 5.10 with a gradual decrement of the activity from pH 5.4, the 
activity at neutral and alkaline pH is about 4 times lower than the highest.-Galactosidase 
shows also the highest activity at pH 5.10 with a sudden drop of the curve and practically no 
activity already at alkaline pH. The two isoforms of -glucosidase show different trends in 
enzyme activities: on the one hand CBE sensitive -glucosidase activity is very high at acidic 
pH (with highest activity at pH 6.2) while it decrease starting from neutral pH and reaching 3 
time less value at alkaline pH; on the other GBA2 -glucosidase shows the highest activity at 
5.7 pH (twice than at 5.0 pH) and, after this value, there is a gradual decrease of the activity. 
Finally -hexosaminidases presents very high activity at 5.0 pH with gradual decrease of it 
until three times lower activity at alkaline pH, while -hexosaminidases A has the same 
course but with a peak at 5.2 pH. 
For the two isoforms of -glucosidase we performed, working at the best pH conditions, also 
kinetics experiments in order to determine Km and Vmax parameters. The values founded 
resulted different from those already published obtained by the cell free assay. This 
difference is not so surprising because in this assay we evaluated the kinetics parameters of 
enzyme that residing  and working in their natural environment. 
So, what we found in this first group of experiments was that the plasma membrane 
associated enzymes showed acidic pH as best pH working conditions. This can be 
considerate strange because this enzyme is associated to the plasma membrane whose pH is 
usually defined neutral. However in the plasma membrane there are different proton pumps 
that can locally shift the pH from neutral values to acidic ones (222, 226). Moreover also the 
extracellular environment could play an important role. In particular situations, as in the 
tumor core or during inflammatory events, it is possible to observe an acidification of the 
cellular environment. We can so speculate that these enzymatic activities could be varied 
directly by the cells through the modulations of proton pumps or indirectly by phenomena 
that change the extracellular environment.  
For this reason, we set up a second group of experiments using EIPA, the specific inhibitor of 
NHEs exchangers, in order to verify whether the varying of membrane potential acting on 
these pumps can influence also the activity of PM-glycohydrolases. For each enzyme we set 
up the assay using 0,1 M and 1 M EIPA versus control. What we can achieve from the 
graphs (Figure 34-39) is that 0,1 M EIPA doesn’t have any effect on the activity of the 
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enzymes, this is in accord to data already publisced showing that this concentration is not 
sufficient for the inhibitions of the NHEs proton pumps present at the plasma membrane 
level. 1 M EIPA has, contrariwise, effect on some of the enzymes. We can see a small 
decrease (30%) of the activity of-galactosidase, while there is a huge decrease on the 
activity of both the two -glucosidase isoforms: the one of CBE sensitive -glucosidase 
diminishes of the 71% after the administration of 1 M EIPA while the one of GBA2 -
glucosidase was reduced of the 59%. Surprisingly, however, the activity of -hexosaminidase 
(and -hexosaminidase A) is nowise influenced by the administration of 1 M EIPA and this 
could be related to a different localization of the enzyme on the plasma membrane, where 
the NHEs exchangers doesn’t reside. So, we can speculate that the activity of this enzyme 
could be regulated by different proton pumps from that one and we are going to try 
different inhibitors from EIPA to study the action of others exchangers. 
After having developed the method of evaluation of PM glycohydrolases we decided to use 
it in order to evaluate if these plasma membrane associated enzymes could be involved in 
the neuronal differentiation. 
During neuronal development it was possible to observe dramatic changes in the 
glycosphingolipids content that cause a parallel reorganization of the PM lipid domains 
enriched in glycosphingolipids (54, 56, 251). The driving forces guiding these modifications 
are not completely understood, however some information regarding the possibility of a fine 
tuning of cell PM glycolipid composition have already been obtained in other cellular models 
where it has been observed a synergy among different glycohydrolases associated with the 
cell surface (1, 3). Rat cerebellar granule cells represent a suitable in vitro model of neuronal 
cells as demonstrated by morphological and biochemical approaches. In rat cerebellar 
granule cells it has been observed an increase of the total cell ceramide content (8 fold from 
the 2nd to the 17th day in culture) (56) and of that belonging to the sphingolipid-enriched 
domains (10 fold from the 2nd to the 17th day in culture) (232), whereas a parallel reduction of 
the endogenous content of both sphingomyelin and gangliosides was observed in 
sphingolipid-enriched domains of senescent cells respect to fully differentiated neurons (56). 
The increase of ceramide could thus be explained with the well-known ceramide-
sphingomyelin cycle, that has been widely demonstrated to be correlated to the apoptotic 
phenomena (258). Nevertheless the increased activity of the PM associated glycohydrolases 
during the cell aging (Figure 43), can let speculate that the augmented ceramide in the PM 
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could also derive from the catabolism of glycosphingolipids directly at the cell surface, as it 
has been previously demonstrated in human fibroblasts (1). As it was reported (97, 98), the 
sialidase Neu3 is able to influence the protrusion and symmetry of axons in neuronal cells 
probably by a local change of the PM sphingolipid composition at the axonal cones., in my 
experiments I obtained different activity of Neu3 during the day in culture reaching the 
maximum activity after the 8 day when the granul cell are morphologically and biochemically 
fully differentiated neurons. We can thus hypothesize that the modulation of the activities of 
other PM-associated glycohydrolases during the neuronal differentiation could be functional 
to the differentiation itself, and could also be useful to define the curvature properties of 
specific area of the PM (such as the synapses or the negative curvature of the membrane 
near the axon protrusion) by an in situ modification of the glycosphingolipids components. In 
particular, considering the typical geometry of the synapses, characterized by the succession 
of PM regions with negative and positive curvatures, that can be correlated respectively to a 
major presence of simple sphingolipids or to an enrichment of more complex 
glycosphingolipids (259), we could speculate that the balance between glycosylation and de-
glycosylation events at the cell surface could be a very important mechanism responsible to 
establish and maintain this local membrane curvature during the cell life.  
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